Dengue virus infection – a review of pathogenesis, vaccines, diagnosis and therapy

•Reviews on unsolved issues of DENV from different perspectives such as the effect of antibody dependent enhancement, immune escape and limitations of commercial diagnostic kits.•Case studies on variety of potential therapeutic candidates targeting on DENV such as peptide inhibitors, broadly neutral...

Full description

Saved in:
Bibliographic Details
Published inVirus research Vol. 324; p. 199018
Main Authors Kok, Boon Hui, Lim, Hui Ting, Lim, Chin Peng, Lai, Ngit Shin, Leow, Chiuan Yee, Leow, Chiuan Herng
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier B.V 15.01.2023
Subjects
Online AccessGet full text

Cover

Loading…
Abstract •Reviews on unsolved issues of DENV from different perspectives such as the effect of antibody dependent enhancement, immune escape and limitations of commercial diagnostic kits.•Case studies on variety of potential therapeutic candidates targeting on DENV such as peptide inhibitors, broadly neutralizing antibodies, engineered antibody, vaccine candidates and antiviral agents.•Exploring different approaches for the improvisation of DENV diagnosis such as application of bio-functionalized tapered optical fiber, nanobody derivatives and antibody engineering. The transmission of dengue virus (DENV) from an infected Aedes mosquito to a human, causes illness ranging from mild dengue fever to fatal dengue shock syndrome. The similar conserved structure and sequence among distinct DENV serotypes or different flaviviruses has resulted in the occurrence of cross reaction followed by antibody-dependent enhancement (ADE). Thus far, the vaccine which can provide effective protection against infection by different DENV serotypes remains the biggest hurdle to overcome. Therefore, deep investigation is crucial for the potent and effective therapeutic drugs development. In addition, the cross-reactivity of flaviviruses that leads to false diagnosis in clinical settings could result to delay proper intervention management. Thus, the accurate diagnostic with high specificity and sensitivity is highly required to provide prompt diagnosis in respect to render early treatment for DENV infected individuals. In this review, the recent development of neutralizing antibodies, antiviral agents, and vaccine candidates in therapeutic platform for DENV infection will be discussed. Moreover, the discovery of antigenic cryptic epitopes, principle of molecular mimicry, and application of single-chain or single-domain antibodies towards DENV will also be presented.
AbstractList •Reviews on unsolved issues of DENV from different perspectives such as the effect of antibody dependent enhancement, immune escape and limitations of commercial diagnostic kits.•Case studies on variety of potential therapeutic candidates targeting on DENV such as peptide inhibitors, broadly neutralizing antibodies, engineered antibody, vaccine candidates and antiviral agents.•Exploring different approaches for the improvisation of DENV diagnosis such as application of bio-functionalized tapered optical fiber, nanobody derivatives and antibody engineering. The transmission of dengue virus (DENV) from an infected Aedes mosquito to a human, causes illness ranging from mild dengue fever to fatal dengue shock syndrome. The similar conserved structure and sequence among distinct DENV serotypes or different flaviviruses has resulted in the occurrence of cross reaction followed by antibody-dependent enhancement (ADE). Thus far, the vaccine which can provide effective protection against infection by different DENV serotypes remains the biggest hurdle to overcome. Therefore, deep investigation is crucial for the potent and effective therapeutic drugs development. In addition, the cross-reactivity of flaviviruses that leads to false diagnosis in clinical settings could result to delay proper intervention management. Thus, the accurate diagnostic with high specificity and sensitivity is highly required to provide prompt diagnosis in respect to render early treatment for DENV infected individuals. In this review, the recent development of neutralizing antibodies, antiviral agents, and vaccine candidates in therapeutic platform for DENV infection will be discussed. Moreover, the discovery of antigenic cryptic epitopes, principle of molecular mimicry, and application of single-chain or single-domain antibodies towards DENV will also be presented.
The transmission of dengue virus (DENV) from an infected Aedes mosquito to a human, causes illness ranging from mild dengue fever to fatal dengue shock syndrome. The similar conserved structure and sequence among distinct DENV serotypes or different flaviviruses has resulted in the occurrence of cross reaction followed by antibody-dependent enhancement (ADE). Thus far, the vaccine which can provide effective protection against infection by different DENV serotypes remains the biggest hurdle to overcome. Therefore, deep investigation is crucial for the potent and effective therapeutic drugs development. In addition, the cross-reactivity of flaviviruses that leads to false diagnosis in clinical settings could result to delay proper intervention management. Thus, the accurate diagnostic with high specificity and sensitivity is highly required to provide prompt diagnosis in respect to render early treatment for DENV infected individuals. In this review, the recent development of neutralizing antibodies, antiviral agents, and vaccine candidates in therapeutic platform for DENV infection will be discussed. Moreover, the discovery of antigenic cryptic epitopes, principle of molecular mimicry, and application of single-chain or single-domain antibodies towards DENV will also be presented.The transmission of dengue virus (DENV) from an infected Aedes mosquito to a human, causes illness ranging from mild dengue fever to fatal dengue shock syndrome. The similar conserved structure and sequence among distinct DENV serotypes or different flaviviruses has resulted in the occurrence of cross reaction followed by antibody-dependent enhancement (ADE). Thus far, the vaccine which can provide effective protection against infection by different DENV serotypes remains the biggest hurdle to overcome. Therefore, deep investigation is crucial for the potent and effective therapeutic drugs development. In addition, the cross-reactivity of flaviviruses that leads to false diagnosis in clinical settings could result to delay proper intervention management. Thus, the accurate diagnostic with high specificity and sensitivity is highly required to provide prompt diagnosis in respect to render early treatment for DENV infected individuals. In this review, the recent development of neutralizing antibodies, antiviral agents, and vaccine candidates in therapeutic platform for DENV infection will be discussed. Moreover, the discovery of antigenic cryptic epitopes, principle of molecular mimicry, and application of single-chain or single-domain antibodies towards DENV will also be presented.
The transmission of dengue virus (DENV) from an infected Aedes mosquito to a human, causes illness ranging from mild dengue fever to fatal dengue shock syndrome. The similar conserved structure and sequence among distinct DENV serotypes or different flaviviruses has resulted in the occurrence of cross reaction followed by antibody-dependent enhancement (ADE). Thus far, the vaccine which can provide effective protection against infection by different DENV serotypes remains the biggest hurdle to overcome. Therefore, deep investigation is crucial for the potent and effective therapeutic drugs development. In addition, the cross-reactivity of flaviviruses that leads to false diagnosis in clinical settings could result to delay proper intervention management. Thus, the accurate diagnostic with high specificity and sensitivity is highly required to provide prompt diagnosis in respect to render early treatment for DENV infected individuals. In this review, the recent development of neutralizing antibodies, antiviral agents, and vaccine candidates in therapeutic platform for DENV infection will be discussed. Moreover, the discovery of antigenic cryptic epitopes, principle of molecular mimicry, and application of single-chain or single-domain antibodies towards DENV will also be presented.
ArticleNumber 199018
Author Leow, Chiuan Yee
Lai, Ngit Shin
Lim, Hui Ting
Kok, Boon Hui
Lim, Chin Peng
Leow, Chiuan Herng
Author_xml – sequence: 1
  givenname: Boon Hui
  surname: Kok
  fullname: Kok, Boon Hui
  organization: Institute for Research in Molecular Medicine (INFORMM), Universiti Sains Malaysia, Gelugor, Penang 11800, Malaysia
– sequence: 2
  givenname: Hui Ting
  surname: Lim
  fullname: Lim, Hui Ting
  organization: Institute for Research in Molecular Medicine (INFORMM), Universiti Sains Malaysia, Gelugor, Penang 11800, Malaysia
– sequence: 3
  givenname: Chin Peng
  surname: Lim
  fullname: Lim, Chin Peng
  organization: Institute for Research in Molecular Medicine (INFORMM), Universiti Sains Malaysia, Gelugor, Penang 11800, Malaysia
– sequence: 4
  givenname: Ngit Shin
  surname: Lai
  fullname: Lai, Ngit Shin
  organization: Institute for Research in Molecular Medicine (INFORMM), Universiti Sains Malaysia, Gelugor, Penang 11800, Malaysia
– sequence: 5
  givenname: Chiuan Yee
  surname: Leow
  fullname: Leow, Chiuan Yee
  organization: School of Pharmaceutical Sciences, Universiti Sains Malaysia, Gelugor, Penang 11800, Malaysia
– sequence: 6
  givenname: Chiuan Herng
  orcidid: 0000-0003-0849-428X
  surname: Leow
  fullname: Leow, Chiuan Herng
  email: herng.leow@usm.my
  organization: Institute for Research in Molecular Medicine (INFORMM), Universiti Sains Malaysia, Gelugor, Penang 11800, Malaysia
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36493993$$D View this record in MEDLINE/PubMed
BookMark eNqFkctOGzEUhi0EKgn0FZCXXTCpb_HYUhetoDcJiQ2sLY_nTOIosYM9E5Qd78Ab8iR1SOiCDatjHX3_L53PY3QcYgCELiiZUELl18Vk49OQE-QJI4xNqNaEqiM0oqpmVS00O0ajAqqK1oSdonHOC0KI5LX8hE65FJprzUfo7hrCbAD82oZ96MD1Pgb88vSMLU6w8fCIY4fXtp_HGQTIPl_ijXXOl_clbr2dhViW2IYW93NIdr09RyedXWb4fJhn6P7Xz7urP9XN7e-_Vz9uKieo7KvaSacp17JmWlpVzlC2E1wIq6dlQRo-FaxWHVEgCDRNYxvCRQusEy0BR_kZ-rLvXaf4MEDuzcpnB8ulDRCHbFg95UxrpXboxQEdmhW0Zp38yqateTNRALkHXIq5eO3-I5SYnXKzMG_KzU652SsvwW_vgs73diexT9YvP45_38ehiCq2k8nOQ3DQ-lT-wrTRf1TxDwzMokk
CitedBy_id crossref_primary_10_3389_fimmu_2025_1487284
crossref_primary_10_3390_axioms12080773
crossref_primary_10_1016_j_diagmicrobio_2025_116679
crossref_primary_10_3390_v16050787
crossref_primary_10_1002_ima_23020
crossref_primary_10_1055_s_0043_1777104
crossref_primary_10_3390_md21090496
crossref_primary_10_3389_fmicb_2024_1423044
crossref_primary_10_1021_acs_jpcb_4c05943
crossref_primary_10_1186_s12967_024_05561_5
crossref_primary_10_36290_ped_2024_046
crossref_primary_10_1007_s11262_024_02095_2
crossref_primary_10_3390_diagnostics14050533
crossref_primary_10_3390_v17010106
crossref_primary_10_4103_2221_6189_390392
crossref_primary_10_1002_ccr3_9079
crossref_primary_10_1128_mra_00162_24
crossref_primary_10_1149_1945_7111_ad8520
crossref_primary_10_1371_journal_pntd_0012914
crossref_primary_10_3389_fmicb_2024_1474406
crossref_primary_10_3390_vaccines13030264
crossref_primary_10_1089_vim_2024_0087
crossref_primary_10_1016_j_meegid_2025_105731
crossref_primary_10_5501_wjv_v14_i1_100489
crossref_primary_10_1016_j_meegid_2024_105710
crossref_primary_10_1016_j_procs_2024_10_273
crossref_primary_10_1007_s13337_025_00915_z
crossref_primary_10_3389_fmicb_2023_1323231
crossref_primary_10_1080_00032719_2025_2476592
crossref_primary_10_1016_j_bcp_2025_116839
crossref_primary_10_1016_j_actatropica_2024_107493
crossref_primary_10_1128_aac_01651_24
crossref_primary_10_1016_j_fmc_2024_02_007
crossref_primary_10_1016_j_micpath_2024_107055
crossref_primary_10_1080_23744235_2024_2348631
crossref_primary_10_1002_hsr2_70144
crossref_primary_10_1016_j_idcr_2024_e01993
crossref_primary_10_1016_j_jointm_2023_07_007
crossref_primary_10_1038_s41598_024_61127_x
crossref_primary_10_1002_jmv_29729
crossref_primary_10_1128_jvi_01258_23
crossref_primary_10_1002_jmv_29775
crossref_primary_10_1016_j_jsb_2025_108196
crossref_primary_10_7759_cureus_46713
crossref_primary_10_3390_v17010006
crossref_primary_10_1186_s12985_024_02608_3
crossref_primary_10_1021_acs_jafc_4c05708
crossref_primary_10_22207_JPAM_18_3_25
crossref_primary_10_1002_prot_26529
crossref_primary_10_1016_j_bioorg_2025_108240
crossref_primary_10_1016_j_ajem_2024_05_022
crossref_primary_10_1016_j_tmaid_2025_102840
crossref_primary_10_3390_microorganisms11020243
crossref_primary_10_3390_v17010057
crossref_primary_10_3390_insects15110898
crossref_primary_10_1021_acs_jpcb_4c05388
crossref_primary_10_1097_IO9_0000000000000017
crossref_primary_10_3389_fmicb_2023_1245416
crossref_primary_10_1042_BSR20240134
crossref_primary_10_1016_j_heliyon_2025_e41939
Cites_doi 10.1146/annurev-virology-110615-042334
10.1128/JCM.00777-06
10.1158/0008-5472.CAN-03-3935
10.1038/nature02165
10.3389/fimmu.2017.00653
10.1371/journal.pntd.0000811
10.1038/srep28768
10.1099/vir.0.82537-0
10.1128/JVI.00867-15
10.1128/microbiolspec.AID-0022-2014
10.1128/JVI.01249-13
10.4049/jimmunol.1600323
10.1111/imr.12367
10.1016/S1473-3099(10)70166-3
10.1021/acs.analchem.5b00762
10.1038/s41598-017-10901-1
10.1016/j.chom.2007.03.002
10.1371/journal.pone.0050995
10.3201/eid2102.141553
10.1046/j.1365-2893.1997.00068.x
10.1038/s41590-018-0210-3
10.1056/NEJMoa1506223
10.1038/nature03956
10.3390/v14020242
10.1128/JVI.00221-16
10.1084/jem.146.1.201
10.1038/emboj.2009.245
10.1093/cid/cis530
10.1016/S0140-6736(94)92678-6
10.1016/j.chom.2012.04.006
10.1038/s41564-020-0714-0
10.11622/smedj.2018008
10.4103/0972-9062.141759
10.1016/j.vaccine.2008.11.061
10.1186/s12879-014-0570-8
10.1111/cbdd.12576
10.1016/j.chom.2009.03.007
10.1371/journal.pone.0061232
10.1016/j.bmc.2019.07.038
10.1056/NEJMra1110265
10.1007/s00430-009-0116-7
10.1016/j.talanta.2011.09.012
10.1128/JVI.01440-10
10.1371/journal.pntd.0005584
10.1128/JVI.02381-05
10.1016/S0140-6736(18)32560-1
10.1371/journal.pntd.0000360
10.1007/978-981-10-8727-1_17
10.1016/j.cell.2018.11.028
10.1155/2012/151967
10.1038/s41598-018-35923-1
10.1128/AAC.01429-12
10.1097/INF.0b013e318150666d
10.2174/138161210793292555
10.1016/j.chom.2010.08.007
10.1016/S0140-6736(15)61273-9
10.1038/nm1240
10.1371/journal.ppat.1005277
10.1038/375291a0
10.1016/j.jcv.2004.04.010
10.1016/j.jviromet.2018.04.009
10.1128/JVI.77.13.7539-7544.2003
10.1128/CVI.00229-06
10.3390/v13071219
10.3201/eid1408.080287
10.1371/journal.pone.0113411
10.1021/acs.analchem.9b02096
10.1016/j.snb.2017.11.005
10.1109/JSEN.2018.2813385
10.1128/JVI.75.16.7769-7773.2001
10.1371/journal.ppat.1002930
10.2147/IJN.S279094
10.1038/srep29201
10.1038/s41598-020-69515-9
10.1196/annals.1348.065
10.1016/j.mib.2008.06.004
10.1073/pnas.0305892101
10.1016/j.vaccine.2005.07.059
10.3390/antib2010066
10.1371/journal.pbio.1001120
10.1073/pnas.1105079108
10.1016/j.bios.2014.04.017
10.1016/j.jviromet.2007.09.001
10.1128/JVI.73.6.4738-4747.1999
10.1002/rmv.2161
10.1016/B978-0-12-625380-1.50010-2
10.1016/j.antiviral.2013.07.019
10.1016/S1473-3099(17)30166-4
10.1128/JCM.40.5.1840-1844.2002
10.1038/ncomms14722
10.1086/518007
10.1086/315215
10.1042/BJ20112219
10.1128/CMR.00035-09
10.1016/j.vaccine.2015.09.108
10.1371/journal.ppat.1002934
10.1126/science.1153263
10.1073/pnas.2003056117
10.4049/jimmunol.166.3.1499
10.1016/j.chom.2009.04.001
10.1016/j.molimm.2006.07.299
10.1371/journal.ppat.1000632
10.1016/S0255-0857(21)02943-1
10.1080/22221751.2020.1775131
10.1073/pnas.0832193100
10.1089/vbz.2008.0176
10.1038/nature12060
10.1093/infdis/jiw649
10.1371/journal.pntd.0001636
10.15252/embr.201745302
10.1126/scitranslmed.aan1589
10.1016/j.mjafi.2014.09.011
10.1016/j.diagmicrobio.2013.12.019
10.1039/C4RA00198B
10.1128/JCM.03042-14
10.1002/rmv.405
10.1016/j.jcv.2013.10.021
10.1016/j.febslet.2012.02.047
10.1016/S1473-3099(20)30158-4
10.1021/acs.jmedchem.9b00759
10.1038/s41598-017-07308-3
10.1038/nm887
10.1016/j.str.2004.06.019
10.1016/j.canlet.2010.08.011
10.1099/vir.0.18723-0
10.1016/j.vaccine.2010.11.050
10.1016/j.jim.2020.112746
10.1016/j.idcr.2020.e00927
10.1007/s00216-006-0549-4
10.1128/CVI.05285-11
10.1089/088282403763635465
10.1007/s10867-020-09548-3
10.1016/B978-0-12-819400-3.00016-8
10.1038/nrmicro2595
10.1371/journal.pone.0180669
10.1371/journal.pone.0017665
10.3201/eid1503.080923
10.1038/nrmicro2459
10.1038/s41467-018-07667-z
10.1016/S1386-6532(01)00250-5
10.1128/JVI.79.13.8004-8013.2005
10.1074/jbc.M110.198754
10.1128/JCM.40.02.376-381.2002
10.1371/journal.pone.0016059
10.1099/vir.0.19228-0
10.3389/fimmu.2020.00479
10.1371/journal.ppat.1000823
10.1021/cr030698+
10.1128/JVI.79.2.1223-1231.2005
10.1186/s12929-015-0164-9
10.1128/JVI.02774-12
10.3390/vaccines7040145
10.1016/S0140-6736(14)60572-9
10.1038/nbt1029
10.1038/ni.3058
10.1111/j.1469-0691.2011.03694.x
10.7554/eLife.08347
10.4269/ajtmh.2010.10-0117
10.1016/j.virol.2014.03.017
10.1186/1743-422X-7-361
10.1371/journal.pone.0020528
10.1073/pnas.1106568108
10.1002/jmv.10261
10.1038/nsmb.1382
10.7150/ijms.21875
10.1371/journal.pone.0092495
10.1016/S0962-8924(98)01373-7
10.1016/j.peptides.2021.170570
10.1038/nature06175
10.1038/ncomms7341
10.1089/omi.2013.0056
10.1172/JCI118964
10.1371/journal.pone.0095263
10.4049/jimmunol.174.12.8163
10.1016/S0065-3527(03)59005-4
10.1016/j.ijid.2020.10.043
10.1128/CVI.00212-08
10.3389/fcimb.2020.580096
10.1016/j.vaccine.2015.05.059
10.1128/CVI.00535-12
10.1038/ncomms13679
10.1038/srep16145
10.1126/science.aaf5316
10.1111/j.1523-1739.2009.01332.x
10.1371/journal.pone.0064056
10.1016/j.bbrc.2012.06.057
10.1186/1743-422X-2-49
10.1016/j.cell.2017.09.002
10.1371/journal.pntd.0001993
10.1111/1348-0421.12757
10.1126/science.342.6157.415
10.1186/1471-2180-14-140
10.1128/JVI.01104-12
10.1080/19420862.2016.1148850
10.1007/s00018-010-0357-z
10.1089/apc.1997.11.429
10.1086/651018
10.1038/s41577-019-0123-x
10.1038/s41586-021-03990-6
10.1128/JVI.75.8.3501-3508.2001
10.1016/j.bmcl.2017.05.027
10.1126/science.1247749
10.4049/jimmunol.1100750
10.1016/j.vaccine.2015.09.101
10.1038/nri3152
10.1590/S0074-02762006000800017
10.1093/femsre/fuu004
10.3390/v8050122
10.1186/1471-2334-10-142
10.1016/j.antiviral.2013.03.018
10.1128/JCM.39.3.977-982.2001
10.1128/JVI.00157-12
10.1007/s40262-013-0079-0
10.1016/S0952-7915(99)80008-9
10.1021/acsinfecdis.7b00110
10.1590/S0036-46652003000100003
10.1038/icb.1964.44
10.15344/2456-4028/2016/101
10.1016/j.diagmicrobio.2007.11.010
10.4103/1995-7645.320520
10.1080/21645515.2019.1658503
10.1128/JCM.41.9.4154-4159.2003
10.1128/JVI.80.5.2170-2182.2006
10.1002/wnan.1584
10.1007/s12104-007-9000-9
10.3390/v14071452
10.1073/pnas.91.7.2395
10.3389/fimmu.2019.01522
10.1038/s41598-019-49891-7
10.4161/mabs.27874
10.1039/c2an36787d
10.1155/2019/7239347
10.1371/journal.pntd.0007202
10.1126/scitranslmed.aal5088
10.1086/520581
10.1016/j.chom.2008.08.004
10.1126/science.1153264
10.1093/clinids/19.3.500
10.1128/CVI.00462-10
ContentType Journal Article
Copyright 2022
Copyright © 2022. Published by Elsevier B.V.
Copyright_xml – notice: 2022
– notice: Copyright © 2022. Published by Elsevier B.V.
DBID 6I.
AAFTH
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1016/j.virusres.2022.199018
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1872-7492
ExternalDocumentID 36493993
10_1016_j_virusres_2022_199018
S0168170222003471
Genre Research Support, Non-U.S. Gov't
Journal Article
Review
GroupedDBID ---
--K
--M
.~1
0R~
0SF
123
1B1
1RT
1~.
1~5
4.4
457
4G.
5RE
5VS
6I.
7-5
71M
8P~
9JM
AAAJQ
AABNK
AACTN
AAEDT
AAEDW
AAFTH
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AARKO
AAXUO
ABBQC
ABFRF
ABJNI
ABLVK
ABMAC
ABMZM
ABYKQ
ACDAQ
ACGFO
ACGFS
ACIUM
ACRLP
ADBBV
ADEZE
AEBSH
AEFWE
AEKER
AENEX
AFKWA
AFTJW
AFXIZ
AGEKW
AGHFR
AGUBO
AGYEJ
AIEXJ
AIKHN
AITUG
AJOXV
AJRQY
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ANZVX
AXJTR
BKOJK
BLXMC
BNPGV
CJTIS
CNWQP
CS3
DU5
EBS
EFJIC
EFLBG
EO8
EO9
EP2
EP3
F5P
FDB
FIRID
FNPLU
FYGXN
G-Q
GBLVA
GROUPED_DOAJ
IH2
IHE
J1W
KOM
LCYCR
LUGTX
M41
MO0
N9A
O-L
O9-
OAUVE
OZT
P-8
P-9
P2P
PC.
Q38
ROL
RPM
RPZ
SCC
SDF
SDG
SDP
SES
SIN
SPCBC
SSH
SSI
SSZ
T5K
WH7
~G-
.GJ
29Q
53G
AAHBH
AAQXK
AATTM
AAXKI
AAYWO
AAYXX
ABFNM
ABWVN
ABXDB
ACIEU
ACRPL
ACVFH
ADCNI
ADMUD
ADNMO
ADVLN
AEIPS
AEUPX
AFJKZ
AFPUW
AGCQF
AGQPQ
AGRNS
AHHHB
AIGII
AIIUN
AKBMS
AKRWK
AKYEP
ANKPU
APXCP
ASPBG
AVWKF
AZFZN
CITATION
EJD
FEDTE
FGOYB
G-2
HMG
HVGLF
HZ~
R2-
RIG
SEW
WUQ
ZGI
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c416t-7c6c913967296a80228af4344a9596a0b354278f08e40ebbbab034de2f4d0ec13
IEDL.DBID .~1
ISSN 0168-1702
1872-7492
IngestDate Thu Jul 10 22:08:46 EDT 2025
Wed Feb 19 02:24:04 EST 2025
Tue Jul 01 01:45:34 EDT 2025
Thu Apr 24 23:09:53 EDT 2025
Fri Feb 23 02:37:56 EST 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords Development
Therapeutic
Diagnostic
DENV
Cross reaction
Language English
License This is an open access article under the CC BY license.
Copyright © 2022. Published by Elsevier B.V.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c416t-7c6c913967296a80228af4344a9596a0b354278f08e40ebbbab034de2f4d0ec13
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ORCID 0000-0003-0849-428X
OpenAccessLink https://www.sciencedirect.com/science/article/pii/S0168170222003471
PMID 36493993
PQID 2753299881
PQPubID 23479
ParticipantIDs proquest_miscellaneous_2753299881
pubmed_primary_36493993
crossref_primary_10_1016_j_virusres_2022_199018
crossref_citationtrail_10_1016_j_virusres_2022_199018
elsevier_sciencedirect_doi_10_1016_j_virusres_2022_199018
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2023-01-15
PublicationDateYYYYMMDD 2023-01-15
PublicationDate_xml – month: 01
  year: 2023
  text: 2023-01-15
  day: 15
PublicationDecade 2020
PublicationPlace Netherlands
PublicationPlace_xml – name: Netherlands
PublicationTitle Virus research
PublicationTitleAlternate Virus Res
PublicationYear 2023
Publisher Elsevier B.V
Publisher_xml – name: Elsevier B.V
References Mathew, Kurane, Rothman, Zeng, Brinton, Ennis (bib0132) 1996; 98
Fernandes, Pereira, Luiz, Zuliani, Furtado, Stabeli (bib0063) 2017; 8
Nascimento, Huleatt, Cordeiro, Castanha, George, Grebe, Welte, Brown, Burke, Marques (bib0148) 2018; 257
Huy, Hanh, Thuy, Chung, Nga, Tuan (bib0100) 2011; 86
Pal, Dauner, Mitra, Forshey, Garcia, Morrison, Halsey, Kochel, Wu (bib0154) 2014; 9
Avirutnan, Hauhart, Somnuke, Blom, Diamond, Atkinson (bib0013) 2011; 187
Montecillo-Aguado, Montes-Gómez, García-Cordero, Corzo-Gómez, Vivanco-Cid, Mellado-Sánchez, Muñoz-Medina, Gutiérrez-Castañeda, Santos-Argumedo, González-Bonilla (bib0137) 2019; 2019
Takada, Kawaoka (bib0207) 2003; 13
Thomas, Yoon (bib0214) 2019; 15
Kraivong, Punyadee, Liszewski, Atkinson, Avirutnan (bib0112) 2021; 13
Bhatt, Gething, Brady, Messina, Farlow, Moyes, Drake, Brownstein, Hoen, Sankoh (bib0022) 2013; 496
Amina, Guo (bib0007) 2020; 15
Austin, Dowd, Shrestha, Nelson, Edeling, Johnson, Pierson, Diamond, Fremont (bib0012) 2012; 8
Burton, Saphire, Parren (bib0026) 2001; 260
Ayala-Nunez, Hoornweg, van de Pol, Sjollema, Flipse, van der Schaar, Smit (bib0015) 2016; 6
St John, Rathore, Yap, Ng, Metcalfe, Vasudevan, Abraham (bib0201) 2011; 108
Felix, Romano, Centrone Cde, Rodrigues, Villas-Boas, Araújo, de Matos, Carvalho, Martelli, Kallas (bib0062) 2012; 19
Halstead (bib0083) 2014; 2
Lok, Kostyuchenko, Nybakken, Holdaway, Battisti, Sukupolvi-Petty, Sedlak, Fremont, Chipman, Roehrig (bib0125) 2008; 15
Hacisuleyman, Erman (bib0079) 2020
Xia, Xie, Zou, Noble, Russell, Holthauzen, Choi, White, Shi (bib0239) 2020; 117
Nicholson-Weller, Klickstein (bib0149) 1999; 11
Scaturro, Cortese, Chatel-Chaix, Fischl, Bartenschlager (bib0186) 2015; 11
Deng, Dai, Ji, Jiang, Wang, Yang, Tan, Liu, Yu, Ge (bib0050) 2011; 6
Mustafa, Rasotgi, Jain, Gupta (bib0144) 2015; 71
Troisi, Hollinger (bib0220) 1997; 4
Zou, Huang, Zhang, Wu, Ni, Sun, Dai (bib0249) 2019; 13
Henrina, Putra, Lawrensia, Handoyono, Cahyadi (bib0092) 2020
Martins, Gomes-Neto, Faustino, Carvalho, Carneiro, Bozza, Mohana-Borges, Castanho, Almeida, Santos (bib0130) 2012; 444
Poungpair, Bangphoomi, Chaowalit, Sawasdee, Saokaew, Choowongkomon, Chaicumpa, Yenchitsomanus (bib0169) 2014; 6
Wang, Chao, Lin, King, Chang (bib0227) 2003; 36
Chew, Poh, Poh (bib0039) 2017; 14
.
WHO. (2009). Dengue guidelines for diagnosis, treatment, prevention and control: new edition.
Wong, Haqshenas, Gowans, Mackenzie (bib0235) 2012; 586
Wilder-Smith, Ooi, Horstick, Wills (bib0234) 2019; 393
Zhang, Zhang, Ogata, Clements, Strauss, Baker, Kuhn, Rossmann (bib255) 2004; 12
Kembuan (bib0108) 2020; 22
Liu, Anderson, Delehanty, Baumann, Hayhurst, Goldman (bib0123) 2007; 44
Pierson, Xu, Nelson, Oliphant, Nybakken, Fremont, Diamond (bib0164) 2007; 1
Araújo, Nogueira, de Araújo, Ramalho, Roriz, de Melo, Coelho (bib0011) 2006; 101
Vickers, Harvey, Brown, Nelson, DuCasse, Lindo (bib0222) 2015; 22
Li, Liao, Cheng, Liang, Liu, Chiu, Lin, Chang, Wu (bib0119) 2012; 6
Mapalagamage, Weiskopf, Sette, De Silva (bib0128) 2022; 14
Teo, Chu (bib0212) 2014; 88
Campos, Mongkolsapaya, Screaton (bib0030) 2018; 19
Modis, Ogata, Clements, Harrison (bib0133) 2004; 427
Mongkolsapaya, Dejnirattisai, Xu, Vasanawathana, Tangthawornchaikul, Chairunsri, Sawasdivorn, Duangchinda, Dong, Rowland-Jones (bib0136) 2003; 9
Hadinegoro, Arredondo-García, Capeding, Deseda, Chotpitayasunondh, Dietze, Muhammad Ismail, Reynales, Limkittikul, Rivera-Medina (bib0080) 2015; 373
Flipse, Diosa-Toro, Hoornweg, van de Pol, Urcuqui-Inchima, Smit (bib0068) 2016; 6
Halstead, S.B. (1980). 5 - Immunological parameters of togavirus disease syndromes. The Togaviruses, 107–173. doi
Ma, Jones, Groesch, Kuhn, Post (bib0126) 2004; 101
Chuansumrit, Chaiyaratana, Pongthanapisith, Tangnararatchakit, Lertwongrath, Yoksan (bib0040) 2008; 27
Martina, Koraka, Osterhaus (bib0129) 2009; 22
Steinman, Banchereau (bib0203) 2007; 449
Vasilakis, Cardosa, Hanley, Holmes, Weaver (bib253) 2011; 9
Dussart, Labeau, Lagathu, Louis, Nunes, Rodrigues, Storck-Herrmann, Cesaire, Morvan, Flamand (bib0057) 2006; 13
Thiemmeca, Tamdet, Punyadee, Prommool, Songjaeng, Noisakran, Puttikhunt, Atkinson, Diamond, Ponlawat (bib0213) 2016; 197
Ranzoni, den Hamer, Karoli, Buechler, Cooper (bib0172) 2015; 87
Fatima, Wang, Kang, Xia, Wang, Ye, Wang, Wang (bib0061) 2014; 9
Harapan, Ryan, Yohan, Abidin, Nainu, Rakib, Jahan, Emran, Ullah, Panta (bib0087) 2021; 31
Rey, Heinz, Mandl, Kunz, Harrison (bib0173) 1995; 375
Wu, Huang, Chao, Jan, Huang, Chiang, King, Shaio (bib0236) 2001; 39
Setthapramote, Sasaki, Puiprom, Limkittikul, Pitaksajjakul, Pipattanaboon, Sasayama, Leuangwutiwong, Phumratanaprapin, Chamnachanan (bib0190) 2012; 423
Masyeni, Santoso, Widyaningsih, Asmara, Nainu, Harapan, Sasmono (bib0131) 2021; 102
WHO. (2021). Dengue and severe dengue. Retrieved from
Sherwood, Hayhurst (bib0192) 2013; 8
Prasitsirikul, Pongpirul, Pongpirul, Panitantum, Ratnarathon, Hemachudha (bib0170) 2020; 9
Kakumani, Ponia, S, Sood, Chinnappan, Banerjea, Medigeshi, Malhotra, Mukherjee, Bhatnagar (bib0103) 2013; 87
Hunsperger, Yoksan, Buchy, Nguyen, Sekaran, Enria, Pelegrino, Vázquez, Artsob, Drebot (bib0098) 2009; 15
Shah, Link, Jang, Sharp, Zhu, Swaney, Johnson, Von Dollen, Ramage, Satkamp (bib0191) 2018; 175
Shu, Chen, Chang, Yueh, Chow, Chien, Chin, Yang, Lin, Huang (bib0196) 2002; 40
Murugesan, A., & Manoharan, M. (2020). Dengue virus. Emerging and Reemerging Viral Pathogens, 281–359. doi
Zhang, Kostyuchenko, Ng, Lim, Ooi, Lambert, Tan, Widman, Shi, Baric (bib0248) 2016; 7
Satija, Karunakaran, Mukherji (bib0185) 2014; 4
Yang, Wang, Beasley, Volk, Zhao, Luxon, Lomas, Herzog, Aronson, Barrett (bib0244) 2006; 1082
Pal, Dauner, Valks, Forshey, Long, Thaisomboonsuk, Sierra, Picos, Talmage, Morrison (bib0155) 2015; 53
Ubol, Phuklia, Kalayanarooj, Modhiran (bib0221) 2010; 201
Kamil, Bakar, Mustapa, Yaacob, Abidin, Syahir, Lee, Mahdi (bib0104) 2018; 257
Modis, Ogata, Clements, Harrison (bib0134) 2005; 79
Shriver-Lake, Liu, Zabetakis, Sugiharto, Lee, Defang, Wu, Anderson, Goldman (bib0195) 2018; 8
Guzman, Harris (bib0076) 2015; 385
Qiu, Di, Wen, Wang, Liang, Wang, Pan, Wang, Ding, Che (bib0171) 2009; 16
Eggleton, Reid, Tenner (bib0059) 1998; 8
Rothan, Bahrani, Rahman, Yusof (bib0178) 2014; 14
Kyle, Beatty, Harris (bib0113) 2007; 195
Aguirre, Maestre, Pagni, Patel, Savage, Gutman, Maringer, Bernal-Rubio, Shabman, Simon (bib0002) 2012; 8
Lin, Lei, Shiau, Liu, Liu, Yeh, Chen, Lin (bib0121) 2003; 69
Sánchez-Purrà, Carré-Camps, de Puig, Bosch, Gehrke, Hamad-Schifferli (bib0182) 2017; 3
Guy, Briand, Lang, Saville, Jackson (bib0075) 2015; 33
Libraty, Pichyangkul, Ajariyakhajorn, Endy, Ennis (bib0120) 2001; 75
Pinto, Assis, Vallochi, Pacheco, Lima, Quaresma, Pereira, Costa, Alves (bib0165) 2019; 10
Hrobowski, Garry, Michael (bib0096) 2005; 2
Welsch, Miller, Romero-Brey, Merz, Bleck, Walther, Fuller, Antony, Krijnse-Locker, Bartenschlager (bib0228) 2009; 5
Chaturvedi, Shrivastava (bib0037) 2004; 22
Volk, Gandham, May, Anderson, Barrett, Gorenstein (bib0223) 2007; 1
Shrestha, Brien, Sukupolvi-Petty, Austin, Edeling, Kim, O'Brien, Nelson, Johnson, Fremont (bib0194) 2010; 6
Takada, Ebihara, Feldmann, Geisbert, Kawaoka (bib0205) 2007; 196
George, Valiant, Mattapallil, Walker, Huang, Vanlandingham, Misamore, Greenhouse, Weiss, Verthelyi (bib0070) 2017; 7
Taylor-Robinson (bib0210) 2016; 1
Dorigatti, Aguas, Donnelly, Guy, Coudeville, Jackson, Saville, Ferguson (bib0053) 2015; 33
Lebani, Jones, Watterson, Ranzoni, Traves, Young, Mahler (bib0117) 2017; 12
Cruz-Oliveira, Freire, Conceição, Higa, Castanho, Da Poian (bib0046) 2015; 39
Wesolowski, Alzogaray, Reyelt, Unger, Juarez, Urrutia, Cauerhff, Danquah, Rissiek, Scheuplein (bib0230) 2009; 198
Gowri Sankar, Dhananjeyan, Paramasivan, Thenmozhi, Tyagi, John Vennison (bib0071) 2012; 18
Paranavitane, Gomes, Kamaladasa, Adikari, Wickramasinghe, Jeewandara, Shyamali, Ogg, Malavige (bib0158) 2014; 14
St John, Rathore (bib0202) 2019; 19
Cabezas, Rojas, Pavon, Alvarez, Pupo, Guillen, Guzman (bib0029) 2008; 147
Muñoz-Jordán, Laurent-Rolle, Ashour, Martínez-Sobrido, Ashok, Lipkin, García-Sastre (bib0141) 2005; 79
11(6), 429–433. doi
Takagi, Matsui, Nobori, Maeda, Sato, Kurosu, Orba, Sawa, Hattori, Higashino (bib0208) 2017; 27
Wang, Bardelli, Espinosa, Pedotti, Ng, Bianchi, Simonelli, Lim, Foglierini, Zatta (bib0225) 2017; 171
Xu, Vaughan, Weiskopf, Grifoni, Diamond, Sette, Peters (bib0241) 2016; 8
Dupont-Rouzeyrol, O'Connor, Calvez, Daurès, John, Grangeon, Gourinat (bib0056) 2015; 21
Ho, Hung, Weng, Wu, Chou, Lin, Chang, Tai, Lai (bib0093) 2005; 174
Sirohi, Chen, Sun, Klose, Pierson, Rossmann, Kuhn (bib0199) 2016; 352
Cherrier, Kaufmann, Nybakken, Lok, Warren, Chen, Nelson, Kostyuchenko, Holdaway, Chipman (bib0038) 2009; 28
Kanesa-thasan, Iacono-Connors, Magill, Smoak, Vaughn, Dubois, Burrous, Hoke (bib0105) 1994; 343
Rivino (bib0175) 2018; 1062
Yu, Zhang, Holdaway, Li, Kostyuchenko, Chipman, Kuhn, Rossmann, Chen (bib0247) 2008; 319
Schmidt, Yang, Harrison (bib0187) 2010; 84
Beckett, Tjaden, Burgess, Danko, Tamminga, Simmons, Wu, Sun, Kochel, Raviprakash (bib0019) 2011; 29
Wu, Jiang, Ying (bib0238) 2017; 8
Costa, Paes, Barreto, Pinhão, Barth, Queiroz, Armôa, Freire, Alves (bib0044) 2006; 24
Hollmann, Cardoso, Espeche, Maffía (bib0095) 2021; 142
Cardosa, Wang, Sum, Tio (bib0031) 2002; 2
Guzman, Jaenisch, Gaczkowski, Ty Hang, Sekaran, Kroeger, Vazquez, Ruiz, Martinez, Mercado (bib0077) 2010; 4
Pierson, Diamond (bib0162) 2020; 5
Halstead (bib0081) 1970; 42
Liu, Loo, Horner, Zornetzer, Katze, Gale (bib0122) 2012; 11
Kaptein, Goethals, Kiemel, Marchand, Kesteleyn, Bonfanti, Bardiot, Stoops, Jonckers, Dallmeier (bib0106) 2021; 598
Sáez-Llorens, Tricou, Yu, Rivera, Tuboi, Garbes, Borkowski, Wallace (bib0180) 2017; 17
Baneyx, Mujacic (bib0018) 2004; 22
Fernandez-Sesma, Marukian, Ebersole, Kaminski, Park, Yuen, Sealfon, García-Sastre, Moran (bib0065) 2006; 80
Andries, Duong, Ngan, Ong, Huy, Sroin, Te, Y, Try, Buchy (bib0009) 2012; 6
Akey, Brown, Dutta, Konwerski, Jose, Jurkiw, DelProposto, Ogata, Skiniotis, Kuhn (bib0004) 2014; 343
Elshuber, Allison, Heinz, Mandl (bib0060) 2003; 84
Rudel, Defries,
Daniel (10.1016/j.virusres.2022.199018_bib0048) 2004; 104
Fibriansah (10.1016/j.virusres.2022.199018_bib0066) 2015; 6
Thiemmeca (10.1016/j.virusres.2022.199018_bib0213) 2016; 197
Vickers (10.1016/j.virusres.2022.199018_bib0222) 2015; 22
Lin (10.1016/j.virusres.2022.199018_bib0121) 2003; 69
Pierson (10.1016/j.virusres.2022.199018_bib0163) 2008; 4
Colombo (10.1016/j.virusres.2022.199018_bib0042) 2013; 58
Kraivong (10.1016/j.virusres.2022.199018_bib0112) 2021; 13
Perera (10.1016/j.virusres.2022.199018_bib0160) 2008; 11
Byk (10.1016/j.virusres.2022.199018_bib0027) 2016; 3
Songprakhon (10.1016/j.virusres.2022.199018_bib0200) 2020; 10
Halstead (10.1016/j.virusres.2022.199018_bib0085) 1977; 146
Wang (10.1016/j.virusres.2022.199018_bib0225) 2017; 171
Wesolowski (10.1016/j.virusres.2022.199018_bib0230) 2009; 198
Yamada (10.1016/j.virusres.2022.199018_bib0242) 2002; 24
Azevedo (10.1016/j.virusres.2022.199018_bib0016) 2011; 6
Clyde (10.1016/j.virusres.2022.199018_bib0041) 2006; 80
Rodenhuis-Zybert (10.1016/j.virusres.2022.199018_bib0176) 2010; 67
Sáez-Llorens (10.1016/j.virusres.2022.199018_bib0180) 2017; 17
St John (10.1016/j.virusres.2022.199018_bib0201) 2011; 108
Shu (10.1016/j.virusres.2022.199018_bib0196) 2002; 40
Liu (10.1016/j.virusres.2022.199018_bib0122) 2012; 11
Tanaka (10.1016/j.virusres.2022.199018_bib0209) 2006; 385
Dražić (10.1016/j.virusres.2022.199018_bib0055) 2020; 63
Nicholson-Weller (10.1016/j.virusres.2022.199018_bib0149) 1999; 11
10.1016/j.virusres.2022.199018_bib0058
Rothan (10.1016/j.virusres.2022.199018_bib0178) 2014; 14
Youn (10.1016/j.virusres.2022.199018_bib0246) 2012; 86
Ahmed (10.1016/j.virusres.2022.199018_bib0003) 2014; 51
Cabezas (10.1016/j.virusres.2022.199018_bib0029) 2008; 147
Muller (10.1016/j.virusres.2022.199018_bib0140) 2017; 215
Mustapa (10.1016/j.virusres.2022.199018_bib0145) 2018; 18
Rothan (10.1016/j.virusres.2022.199018_bib0179) 2013; 17
Alteri (10.1016/j.virusres.2022.199018_bib0006) 2020
Chan (10.1016/j.virusres.2022.199018_bib0034) 2011; 108
Fernandes (10.1016/j.virusres.2022.199018_bib0063) 2017; 8
Kembuan (10.1016/j.virusres.2022.199018_bib0108) 2020; 22
Rudel (10.1016/j.virusres.2022.199018_bib252) 2009; 23
Mustapha Kamil (10.1016/j.virusres.2022.199018_bib0146) 2019; 9
Whitehead (10.1016/j.virusres.2022.199018_bib0231) 2017; 11
Shi (10.1016/j.virusres.2022.199018_bib0193) 2016; 8
Wong (10.1016/j.virusres.2022.199018_bib0235) 2012; 586
Sherwood (10.1016/j.virusres.2022.199018_bib0192) 2013; 8
Hussack (10.1016/j.virusres.2022.199018_bib0099) 2011; 286
Masyeni (10.1016/j.virusres.2022.199018_bib0131) 2021; 102
Kamil (10.1016/j.virusres.2022.199018_bib0104) 2018; 257
Wang (10.1016/j.virusres.2022.199018_bib0227) 2003; 36
Peeling (10.1016/j.virusres.2022.199018_bib0159) 2010; 8
Hunsperger (10.1016/j.virusres.2022.199018_bib0098) 2009; 15
Pissuwan (10.1016/j.virusres.2022.199018_bib0167) 2020; 12
Kakumani (10.1016/j.virusres.2022.199018_bib0103) 2013; 87
Mathew (10.1016/j.virusres.2022.199018_bib0132) 1996; 98
Morens (10.1016/j.virusres.2022.199018_bib0138) 1994; 19
Hang (10.1016/j.virusres.2022.199018_bib0086) 2009; 3
Kato (10.1016/j.virusres.2022.199018_bib0107) 2016; 8
Pierson (10.1016/j.virusres.2022.199018_bib0161) 2013; 1
Harapan (10.1016/j.virusres.2022.199018_bib0087) 2021; 31
Bhatt (10.1016/j.virusres.2022.199018_bib0022) 2013; 496
Lanciotti (10.1016/j.virusres.2022.199018_bib0115) 2008; 14
Ding (10.1016/j.virusres.2022.199018_bib0052) 2011; 18
Guy (10.1016/j.virusres.2022.199018_bib0075) 2015; 33
Burton (10.1016/j.virusres.2022.199018_bib0026) 2001; 260
Dejnirattisai (10.1016/j.virusres.2022.199018_bib0049) 2015; 16
Hasan (10.1016/j.virusres.2022.199018_bib0088) 2017; 8
Austin (10.1016/j.virusres.2022.199018_bib0012) 2012; 8
Sea (10.1016/j.virusres.2022.199018_bib0189) 2013; 8
Takagi (10.1016/j.virusres.2022.199018_bib0208) 2017; 27
Cardosa (10.1016/j.virusres.2022.199018_bib0031) 2002; 2
Takada (10.1016/j.virusres.2022.199018_bib0207) 2003; 13
Sánchez-Vargas (10.1016/j.virusres.2022.199018_bib0183) 2014; 78
Montecillo-Aguado (10.1016/j.virusres.2022.199018_bib0137) 2019; 2019
Scaturro (10.1016/j.virusres.2022.199018_bib0186) 2015; 11
Zhang (10.1016/j.virusres.2022.199018_bib255) 2004; 12
Satija (10.1016/j.virusres.2022.199018_bib0185) 2014; 4
Leitmeyer (10.1016/j.virusres.2022.199018_bib250) 1999; 73
Fatima (10.1016/j.virusres.2022.199018_bib0061) 2014; 9
Gowri Sankar (10.1016/j.virusres.2022.199018_bib0071) 2012; 18
Costa (10.1016/j.virusres.2022.199018_bib0044) 2006; 24
Hawkes (10.1016/j.virusres.2022.199018_bib0090) 1964; 42
10.1016/j.virusres.2022.199018_bib0082
Tirado (10.1016/j.virusres.2022.199018_bib0215) 2003; 16
Cruz-Oliveira (10.1016/j.virusres.2022.199018_bib0046) 2015; 39
Ho (10.1016/j.virusres.2022.199018_bib0094) 2001; 166
Swain (10.1016/j.virusres.2022.199018_bib0204) 2012; 12
Vasilakis (10.1016/j.virusres.2022.199018_bib253) 2011; 9
Alcon (10.1016/j.virusres.2022.199018_bib0005) 2002; 40
Fernandez-Sesma (10.1016/j.virusres.2022.199018_bib0065) 2006; 80
Kou (10.1016/j.virusres.2022.199018_bib0110) 2010; 299
Amina (10.1016/j.virusres.2022.199018_bib0007) 2020; 15
Andries (10.1016/j.virusres.2022.199018_bib0009) 2012; 6
Monath (10.1016/j.virusres.2022.199018_bib0135) 1994; 91
Pierson (10.1016/j.virusres.2022.199018_bib0164) 2007; 1
Qiu (10.1016/j.virusres.2022.199018_bib0171) 2009; 16
Beckett (10.1016/j.virusres.2022.199018_bib0019) 2011; 29
Steinman (10.1016/j.virusres.2022.199018_bib0203) 2007; 449
Gyurech (10.1016/j.virusres.2022.199018_bib0078) 2016; 146
Taylor-Robinson (10.1016/j.virusres.2022.199018_bib0210) 2016; 1
Trilling (10.1016/j.virusres.2022.199018_bib0218) 2013; 138
Gentilucci (10.1016/j.virusres.2022.199018_bib0069) 2010; 16
Schmidt (10.1016/j.virusres.2022.199018_bib0187) 2010; 84
Shriver-Lake (10.1016/j.virusres.2022.199018_bib0195) 2018; 8
Troisi (10.1016/j.virusres.2022.199018_bib0220) 1997; 4
Simon-Lorière (10.1016/j.virusres.2022.199018_bib0198) 2017; 9
Flajnik (10.1016/j.virusres.2022.199018_bib0067) 2011; 9
Pal (10.1016/j.virusres.2022.199018_bib0154) 2014; 9
Joob (10.1016/j.virusres.2022.199018_bib0102) 2018; 59
Shrestha (10.1016/j.virusres.2022.199018_bib0194) 2010; 6
Wenming (10.1016/j.virusres.2022.199018_bib0229) 2005; 32
da Silva-Júnior (10.1016/j.virusres.2022.199018_bib0047) 2019; 27
Kanesa-thasan (10.1016/j.virusres.2022.199018_bib0105) 1994; 343
Eggleton (10.1016/j.virusres.2022.199018_bib0059) 1998; 8
Libraty (10.1016/j.virusres.2022.199018_bib0120) 2001; 75
Byrd (10.1016/j.virusres.2022.199018_bib0028) 2013; 57
dos Santos (10.1016/j.virusres.2022.199018_bib0054) 2003; 45
Aguirre (10.1016/j.virusres.2022.199018_bib0002) 2012; 8
Sasaki (10.1016/j.virusres.2022.199018_bib0184) 2013; 98
Pinto (10.1016/j.virusres.2022.199018_bib0166) 2022; 14
Manoff (10.1016/j.virusres.2022.199018_bib0127) 2015; 33
Shah (10.1016/j.virusres.2022.199018_bib0191) 2018; 175
Lok (10.1016/j.virusres.2022.199018_bib0124) 2012; 7
Chareonsirisuthigul (10.1016/j.virusres.2022.199018_bib0035) 2007; 88
Diao (10.1016/j.virusres.2022.199018_bib0051) 2013; 52
Hacisuleyman (10.1016/j.virusres.2022.199018_bib0079) 2020
Paranavitane (10.1016/j.virusres.2022.199018_bib0158) 2014; 14
Trilling (10.1016/j.virusres.2022.199018_bib0219) 2014; 60
Dupont-Rouzeyrol (10.1016/j.virusres.2022.199018_bib0056) 2015; 21
Fernandez-Garcia (10.1016/j.virusres.2022.199018_bib0064) 2009; 5
Yodsheewan (10.1016/j.virusres.2022.199018_bib0245) 2013; 100
Kaptein (10.1016/j.virusres.2022.199018_bib0106) 2021; 598
Panya (10.1016/j.virusres.2022.199018_bib0157) 2015; 86
Taylor (10.1016/j.virusres.2022.199018_bib0211) 2015; 268
Musso (10.1016/j.virusres.2022.199018_bib0143) 2015; 386
Mustafa (10.1016/j.virusres.2022.199018_bib0144) 2015; 71
Xu (10.1016/j.virusres.2022.199018_bib0241) 2016; 8
Lai (10.1016/j.virusres.2022.199018_bib0114) 2017; 7
Teo (10.1016/j.virusres.2022.199018_bib0212) 2014; 88
Li (10.1016/j.virusres.2022.199018_bib0119) 2012; 6
Osorio (10.1016/j.virusres.2022.199018_bib0153) 2010; 7
Guevarra (10.1016/j.virusres.2022.199018_bib0074) 2020; 64
Modis (10.1016/j.virusres.2022.199018_bib0134) 2005; 79
Hadinegoro (10.1016/j.virusres.2022.199018_bib0080) 2015; 373
Simmons (10.1016/j.virusres.2022.199018_bib0197) 2012; 366
Tricou (10.1016/j.virusres.2022.199018_bib0217) 2010; 10
Modis (10.1016/j.virusres.2022.199018_bib251) 2003; 100
Blacksell (10.1016/j.virusres.2022.199018_bib0023) 2012; 2012
Martins (10.1016/j.virusres.2022.199018_bib0130) 2012; 444
Felix (10.1016/j.virusres.2022.199018_bib0062) 2012; 19
Havenar-Daughton (10.1016/j.virusres.2022.199018_bib0089) 2020; 479
Modis (10.1016/j.virusres.2022.199018_bib0133) 2004; 427
Avirutnan (10.1016/j.virusres.2022.199018_bib0013) 2011; 187
Akey (10.1016/j.virusres.2022.199018_bib0004) 2014; 343
Hrobowski (10.1016/j.virusres.2022.199018_bib0096) 2005; 2
Chatel-Chaix (10.1016/j.virusres.2022.199018_bib0036) 2015; 89
Hollmann (10.1016/j.virusres.2022.199018_bib0095) 2021; 142
Beltramello (10.1016/j.virusres.2022.199018_bib0020) 2010; 8
Halstead (10.1016/j.virusres.2022.199018_bib0081) 1970; 42
Dorigatti (10.1016/j.virusres.2022.199018_bib0053) 2015; 33
Avirutnan (10.1016/j.virusres.2022.199018_bib0014) 2008; 26
Dussart (10.1016/j.virusres.2022.199018_bib0057) 2006; 13
Yu (10.1016/j.virusres.2022.199018_bib0247) 2008; 319
Guzman (10.1016/j.virusres.2022.199018_bib0076) 2015; 385
Thomas (10.1016/j.virusres.2022.199018_bib0214) 2019; 15
Chaturvedi (10.1016/j.virusres.2022.199018_bib0037) 2004; 22
Oliphant (10.1016/j.virusres.2022.199018_bib0152) 2005; 11
Deng (10.1016/j.virusres.2022.199018_bib0050) 2011; 6
Chuansumrit (10.1016/j.virusres.2022.199018_bib0040) 2008; 27
Pok (10.1016/j.virusres.2022.199018_bib0168) 2010; 10
Narayan (10.1016/j.virusres.2022.199018_bib0147) 2020; 10
Wu (10.1016/j.virusres.2022.199018_bib0236) 2001; 39
Wu (10.1016/j.virusres.2022.199018_bib0238) 2017; 8
Liu (10.1016/j.virusres.2022.199018_bib0123) 2007; 44
Li (10.1016/j.virusres.2022.199018_bib0118) 2008; 319
Balmaseda (10.1016/j.virusres.2022.199018_bib0017) 2003; 10
Zhang (10.1016/j.virusres.2022.199018_bib0248) 2016; 7
Pierson (10.1016/j.virusres.2022.199018_bib0162) 2020; 5
Morrison (10.1016/j.virusres.2022.199018_bib
References_xml – volume: 39
  start-page: 977
  year: 2001
  end-page: 982
  ident: bib0236
  article-title: Identification of B-cell epitope of dengue virus type 1 and its application in diagnosis of patients
  publication-title: J. Clin. Microbiol.
– volume: 6
  start-page: e1636
  year: 2012
  ident: bib0119
  article-title: Development of a humanized antibody with high therapeutic potential against dengue virus type 2
  publication-title: PLOS Negl. Trop. Dis.
– volume: 10
  start-page: 142
  year: 2010
  ident: bib0217
  article-title: Comparison of two dengue NS1 rapid tests for sensitivity, specificity and relationship to viraemia and antibody responses
  publication-title: BMC Infect. Dis.
– volume: 44
  start-page: 2872
  year: 2006
  end-page: 2878
  ident: bib0240
  article-title: Serotype 1-specific monoclonal antibody-based antigen capture immunoassay for detection of circulating nonstructural protein NS1: implications for early diagnosis and serotyping of dengue virus infections
  publication-title: J. Clin. Microbiol.
– volume: 1
  start-page: 135
  year: 2007
  end-page: 145
  ident: bib0164
  article-title: The stoichiometry of antibody-mediated neutralization and enhancement of West Nile virus infection
  publication-title: Cell Host Microbe
– volume: 8
  start-page: 271
  year: 2010
  end-page: 283
  ident: bib0020
  article-title: The human immune response to Dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity
  publication-title: Cell Host Microbe
– volume: 8
  start-page: 18086
  year: 2018
  ident: bib0195
  article-title: Selection and characterization of anti-dengue NS1 single domain antibodies
  publication-title: Sci. Rep.
– volume: 456-457
  start-page: 96
  year: 2014
  end-page: 107
  ident: bib0139
  article-title: Abrogation of TLR3 inhibition by discrete amino acid changes in the C-terminal half of the West Nile virus NS1 protein
  publication-title: Virology
– volume: 10
  start-page: 12933
  year: 2020
  ident: bib0200
  article-title: Peptides targeting dengue viral nonstructural protein 1 inhibit dengue virus production
  publication-title: Sci. Rep.
– volume: 6
  start-page: e20528
  year: 2011
  ident: bib0016
  article-title: DNA vaccines against dengue virus type 2 based on truncate envelope protein or its domain III
  publication-title: PLoS ONE
– volume: 84
  start-page: 183
  year: 2003
  end-page: 191
  ident: bib0060
  article-title: Cleavage of protein prM is necessary for infection of BHK-21 cells by tick-borne encephalitis virus
  publication-title: J. Gen. Virol.
– volume: 10
  start-page: 1009
  year: 2010
  end-page: 1016
  ident: bib0168
  article-title: Evaluation of nonstructural 1 antigen assays for the diagnosis and surveillance of dengue in Singapore
  publication-title: Vector Borne Zoonotic Dis.
– volume: 14
  start-page: 299
  year: 2021
  end-page: 308
  ident: bib0021
  article-title: Plasmid DNA encoding neutralizing human monoclonal antibody without enhancing activity protects against dengue virus infection in mice
  publication-title: Asian Pac. J. Trop. Med.
– volume: 14
  start-page: 140
  year: 2014
  ident: bib0178
  article-title: Identification of natural antimicrobial agents to treat dengue infection: in vitro analysis of latarcin peptide activity against dengue virus
  publication-title: BMC Microbiol.
– volume: 10
  start-page: 1522
  year: 2019
  ident: bib0165
  article-title: T cell responses induced by DNA vaccines based on the DENV2 E and NS1 proteins in mice: importance in protection and immunodominant epitope identification
  publication-title: Front. Immunol.
– volume: 171
  start-page: 229
  year: 2017
  end-page: 241
  ident: bib0225
  article-title: A human bi-specific antibody against Zika virus with high therapeutic potential
  publication-title: Cell
– volume: 9
  start-page: 532
  year: 2011
  end-page: 541
  ident: bib253
  article-title: Fever from the forest: prospects for the continued emergence of sylvatic dengue virus and its impact on public health
  publication-title: Nat. Rev. Microbiol.
– volume: 13
  start-page: 387
  year: 2003
  end-page: 398
  ident: bib0207
  article-title: Antibody-dependent enhancement of viral infection: molecular mechanisms and in vivo implications
  publication-title: Rev. Med. Virol.
– volume: 102
  start-page: 152
  year: 2021
  end-page: 154
  ident: bib0131
  article-title: Serological cross-reaction and coinfection of dengue and COVID-19 in Asia: experience from Indonesia
  publication-title: Int. J. Infect. Dis.
– reference: ECDC. (2021). Geographical distribution of dengue cases reported worldwide, 2021. Retrieved from
– volume: 1
  start-page: 49
  year: 2007
  end-page: 50
  ident: bib0223
  article-title: NMR assignments of the yellow fever virus envelope protein domain III
  publication-title: Biomol. NMR Assign.
– volume: 8
  start-page: 428
  year: 1998
  end-page: 431
  ident: bib0059
  article-title: C1q—How many functions? How many receptors?
  publication-title: Trends Cell Biol.
– volume: 201
  start-page: 923
  year: 2010
  end-page: 935
  ident: bib0221
  article-title: Mechanisms of immune evasion induced by a complex of dengue virus and preexisting enhancing antibodies
  publication-title: J. Infect. Dis.
– volume: 86
  start-page: 13486
  year: 2012
  end-page: 13500
  ident: bib0188
  article-title: Noncoding flavivirus RNA displays RNA interference suppressor activity in insect and Mammalian cells
  publication-title: J. Virol.
– volume: 18
  start-page: 2095
  year: 2011
  end-page: 2101
  ident: bib0024
  article-title: Evaluation of six commercial point-of-care tests for diagnosis of acute dengue infections: the need for combining NS1 antigen and IgM/IgG antibody detection to achieve acceptable levels of accuracy
  publication-title: Clin. Vaccine Immunol.
– volume: 44
  start-page: 1775
  year: 2007
  end-page: 1783
  ident: bib0123
  article-title: Selection of cholera toxin specific IgNAR single-domain antibodies from a naïve shark library
  publication-title: Mol. Immunol.
– volume: 5
  year: 2009
  ident: bib0181
  article-title: Dengue virus capsid protein usurps lipid droplets for viral particle formation
  publication-title: PLoS Pathog.
– volume: 8
  start-page: 574
  year: 2016
  end-page: 584
  ident: bib0193
  article-title: A bispecific antibody effectively neutralizes all four serotypes of dengue virus by simultaneous blocking virus attachment and fusion
  publication-title: MAbs
– volume: 84
  start-page: 2771
  year: 2003
  end-page: 2779
  ident: bib0237
  article-title: Identification of a dengue virus type 2 (DEN-2) serotype-specific B-cell epitope and detection of DEN-2-immunized animal serum samples using an epitope-based peptide antigen
  publication-title: J. Gen. Virol.
– reference: Panakitsuwan, S., Yoshihara, N., Hashimoto, N., Miyamura, K., & Chotpitayasunondh, T. (1997). Early diagnosis of vertical HIV infection in infants by rapid detection of immune complex-dissociated HIV p24 antigen. AIDS Patient Care STDs
– volume: 14
  start-page: 570
  year: 2014
  ident: bib0158
  article-title: Dengue NS1 antigen as a marker of severe clinical disease
  publication-title: BMC Infect. Dis.
– volume: 9
  start-page: e95263
  year: 2014
  ident: bib0061
  article-title: Development of VHH antibodies against dengue virus type 2 NS1 and comparison with monoclonal antibodies for use in immunological diagnosis
  publication-title: PLoS ONE
– volume: 36
  start-page: 89
  year: 2003
  end-page: 95
  ident: bib0227
  article-title: Concurrent infections by two dengue virus serotypes among dengue patients in Taiwan
  publication-title: J. Microbiol. Immunol. Infect.
– reference: CDC. (2021). Dengue around the world. Retrieved from
– volume: 342
  start-page: 415
  year: 2013
  ident: bib0150
  article-title: Tropical medicine. Surprising new dengue virus throws a spanner in disease control efforts
  publication-title: Science
– volume: 39
  start-page: 155
  year: 2015
  end-page: 170
  ident: bib0046
  article-title: Receptors and routes of dengue virus entry into the host cells
  publication-title: FEMS Microbiol. Rev.
– volume: 75
  start-page: 3501
  year: 2001
  end-page: 3508
  ident: bib0120
  article-title: Human dendritic cells are activated by dengue virus infection: enhancement by gamma interferon and implications for disease pathogenesis
  publication-title: J. Virol.
– volume: 8
  year: 2016
  ident: bib0107
  article-title: Dengue virus reporter replicon is a valuable tool for antiviral drug discovery and analysis of virus replication mechanisms
  publication-title: Viruses
– volume: 12
  start-page: 136
  year: 2012
  end-page: 148
  ident: bib0204
  article-title: Expanding roles for CD4⁺ T cells in immunity to viruses
  publication-title: Nat. Rev. Immunol.
– volume: 146
  start-page: w14296
  year: 2016
  ident: bib0078
  article-title: False positive dengue NS1 antigen test in a traveller with an acute Zika virus infection imported into Switzerland
  publication-title: Swiss Med. Wkly.
– volume: 12
  start-page: 1607
  year: 2004
  end-page: 1618
  ident: bib255
  article-title: Conformational changes of the flavivirus E glycoprotein
  publication-title: Structure
– volume: 5
  start-page: 318
  year: 2009
  end-page: 328
  ident: bib0064
  article-title: Pathogenesis of flavivirus infections: using and abusing the host cell
  publication-title: Cell Host Microbe
– volume: 6
  start-page: e17665
  year: 2011
  ident: bib0097
  article-title: Llama-derived single domain antibodies to build multivalent, superpotent and broadened neutralizing anti-viral molecules
  publication-title: PLoS ONE
– volume: 22
  start-page: 55
  year: 2015
  ident: bib0222
  article-title: The performance of the SD BIOLINE Dengue DUO® rapid immunochromatographic test kit for the detection of NS1 antigen, IgM and IgG antibodies during a dengue type 1 epidemic in Jamaica
  publication-title: J. Biomed. Sci.
– volume: 444
  start-page: 405
  year: 2012
  end-page: 415
  ident: bib0130
  article-title: The disordered N-terminal region of dengue virus capsid protein contains a lipid-droplet-binding motif
  publication-title: Biochem. J.
– volume: 343
  start-page: 678
  year: 1994
  ident: bib0105
  article-title: Dengue serotypes 2 and 3 in US forces in Somalia
  publication-title: Lancet
– volume: 6
  year: 2010
  ident: bib0194
  article-title: The development of therapeutic antibodies that neutralize homologous and heterologous genotypes of dengue virus type 1
  publication-title: PLoS Pathog.
– volume: 175
  start-page: 1931
  year: 2018
  end-page: 1945
  ident: bib0191
  article-title: Comparative flavivirus-host protein interaction mapping reveals mechanisms of Dengue and Zika virus pathogenesis
  publication-title: Cell
– volume: 9
  start-page: 5242
  year: 2018
  ident: bib0101
  article-title: Role of NS1 antibodies in the pathogenesis of acute secondary dengue infection
  publication-title: Nat. Commun.
– volume: 16
  start-page: 69
  year: 2003
  end-page: 86
  ident: bib0215
  article-title: Antibody-dependent enhancement of virus infection and disease
  publication-title: Viral Immunol.
– volume: 1
  start-page: 101
  year: 2016
  ident: bib0210
  article-title: A putative fifth serotype of Dengue - potential implications for diagnosis, therapy and vaccine design
  publication-title: Int. J. Clin. Med. Microbiol.
– volume: 15
  start-page: 312
  year: 2008
  end-page: 317
  ident: bib0125
  article-title: Binding of a neutralizing antibody to dengue virus alters the arrangement of surface glycoproteins
  publication-title: Nat. Struct. Mol. Biol.
– volume: 9
  year: 2014
  ident: bib0154
  article-title: Evaluation of dengue NS1 antigen rapid tests and ELISA kits using clinical samples
  publication-title: PLoS ONE
– volume: 60
  start-page: 130
  year: 2014
  end-page: 136
  ident: bib0219
  article-title: Orientation of llama antibodies strongly increases sensitivity of biosensors
  publication-title: Biosens. Bioelectron.
– volume: 73
  start-page: 4738
  year: 1999
  end-page: 4747
  ident: bib250
  article-title: Dengue virus structural differences that correlate with pathogenesis
  publication-title: J. Virol
– volume: 6
  start-page: 474
  year: 2014
  end-page: 482
  ident: bib0169
  article-title: Generation of human single-chain variable fragment antibodies specific to dengue virus non-structural protein 1 that interfere with the virus infectious cycle
  publication-title: MAbs
– volume: 3
  start-page: 263
  year: 2016
  end-page: 281
  ident: bib0027
  article-title: Properties and functions of the Dengue virus capsid protein
  publication-title: Annu. Rev. Virol.
– volume: 21
  start-page: 381
  year: 2015
  end-page: 382
  ident: bib0056
  article-title: Co-infection with Zika and dengue viruses in 2 patients, New Caledonia, 2014
  publication-title: Emerg. Infect. Dis.
– volume: 100
  start-page: 226
  year: 2013
  end-page: 237
  ident: bib0245
  article-title: Human monoclonal ScFv specific to NS1 protein inhibits replication of influenza viruses across types and subtypes
  publication-title: Antiviral Res.
– volume: 86
  start-page: 271
  year: 2011
  end-page: 277
  ident: bib0100
  article-title: A novel biosensor based on serum antibody immobilization for rapid detection of viral antigens
  publication-title: Talanta
– volume: 67
  start-page: 2773
  year: 2010
  end-page: 2786
  ident: bib0176
  article-title: Dengue virus life cycle: viral and host factors modulating infectivity
  publication-title: Cell. Mol. Life Sci.
– volume: 27
  start-page: 3963
  year: 2019
  end-page: 3978
  ident: bib0047
  article-title: Peptide derivatives as inhibitors of NS2B-NS3 protease from Dengue, West Nile, and Zika flaviviruses
  publication-title: Bioorg. Med. Chem.
– volume: 598
  start-page: 504
  year: 2021
  end-page: 509
  ident: bib0106
  article-title: A pan-serotype dengue virus inhibitor targeting the NS3-NS4B interaction
  publication-title: Nature
– volume: 17
  start-page: 560
  year: 2013
  end-page: 567
  ident: bib0179
  article-title: Antiviral cationic peptides as a strategy for innovation in global health therapeutics for dengue virus: high yield production of the biologically active recombinant plectasin peptide
  publication-title: OMICS
– volume: 86
  start-page: 1093
  year: 2015
  end-page: 1104
  ident: bib0157
  article-title: A peptide inhibitor derived from the conserved ectodomain region of DENV membrane (M) protein with activity against dengue virus infection
  publication-title: Chem. Biol. Drug Des.
– volume: 257
  start-page: 62
  year: 2018
  end-page: 68
  ident: bib0148
  article-title: Development of antibody biomarkers of long term and recent dengue virus infections
  publication-title: J. Virol. Methods
– volume: 146
  start-page: 201
  year: 1977
  end-page: 217
  ident: bib0085
  article-title: Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody
  publication-title: J. Exp. Med.
– volume: 51
  start-page: 194
  year: 2014
  end-page: 199
  ident: bib0003
  article-title: Comparison of NS1 antigen detection ELISA, real time RT-PCR and virus isolation for rapid diagnosis of dengue infection in acute phase
  publication-title: J. Vector Borne Dis.
– volume: 375
  start-page: 291
  year: 1995
  end-page: 298
  ident: bib0173
  article-title: The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution
  publication-title: Nature
– volume: 22
  start-page: 564
  year: 2009
  end-page: 581
  ident: bib0129
  article-title: Dengue virus pathogenesis: an integrated view
  publication-title: Clin. Microbiol. Rev.
– volume: 11
  start-page: 528
  year: 2012
  end-page: 537
  ident: bib0122
  article-title: The mitochondrial targeting chaperone 14-3-3ε regulates a RIG-I translocon that mediates membrane association and innate antiviral immunity
  publication-title: Cell Host Microbe
– volume: 64
  start-page: 2853
  year: 2004
  end-page: 2857
  ident: bib0043
  article-title: Efficient cancer therapy with a nanobody-based conjugate
  publication-title: Cancer Res.
– reference: WHO. (2021). Dengue and severe dengue. Retrieved from
– volume: 7
  start-page: 6975
  year: 2017
  ident: bib0114
  article-title: Antibodies against modified NS1 wing domain peptide protect against Dengue virus infection
  publication-title: Sci. Rep.
– volume: 196
  start-page: S347
  year: 2007
  end-page: S356
  ident: bib0205
  article-title: Epitopes required for antibody-dependent enhancement of Ebola virus infection
  publication-title: J. Infect. Dis.
– volume: 13
  year: 2021
  ident: bib0112
  article-title: Dengue and the lectin pathway of the complement system
  publication-title: Viruses
– volume: 366
  start-page: 1423
  year: 2012
  end-page: 1432
  ident: bib0197
  article-title: Dengue
  publication-title: N. Engl. J. Med.
– volume: 166
  start-page: 1499
  year: 2001
  end-page: 1506
  ident: bib0094
  article-title: Infection of human dendritic cells by dengue virus causes cell maturation and cytokine production
  publication-title: J. Immunol.
– volume: 8
  year: 2017
  ident: bib0088
  article-title: A human antibody against Zika virus crosslinks the E protein to prevent infection
  publication-title: Nat. Commun.
– volume: 78
  start-page: 368
  year: 2014
  end-page: 372
  ident: bib0183
  article-title: Evaluation of the SD BIOLINE Dengue Duo rapid test in the course of acute and convalescent dengue infections in a Mexican endemic region
  publication-title: Diagn. Microbiol. Infect. Dis.
– volume: 32
  start-page: 194
  year: 2005
  end-page: 198
  ident: bib0229
  article-title: Simultaneous infection with dengue 2 and 3 viruses in a Chinese patient return from Sri Lanka
  publication-title: J. Clin. Virol.
– volume: 343
  start-page: 881
  year: 2014
  end-page: 885
  ident: bib0004
  article-title: Flavivirus NS1 structures reveal surfaces for associations with membranes and the immune system
  publication-title: Science
– volume: 26
  start-page: I100
  year: 2008
  end-page: I107
  ident: bib0014
  article-title: Complement and its role in protection and pathogenesis of flavivirus infections
  publication-title: Vaccine
– volume: 33
  start-page: 3746
  year: 2015
  end-page: 3751
  ident: bib0053
  article-title: Modelling the immunological response to a tetravalent dengue vaccine from multiple phase-2 trials in Latin America and South East Asia
  publication-title: Vaccine
– volume: 14
  start-page: 1342
  year: 2017
  end-page: 1359
  ident: bib0039
  article-title: Peptides as therapeutic agents for Dengue virus
  publication-title: Int. J. Med. Sci.
– volume: 91
  start-page: 9424
  year: 2019
  end-page: 9429
  ident: bib0008
  article-title: Oriented immobilization of single-domain antibodies using SpyTag/SpyCatcher yields improved limits of detection
  publication-title: Anal. Chem.
– volume: 75
  start-page: 7769
  year: 2001
  end-page: 7773
  ident: bib0045
  article-title: Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells
  publication-title: J. Virol.
– volume: 40
  start-page: 1840
  year: 2002
  end-page: 1844
  ident: bib0196
  article-title: Potential application of nonstructural protein NS1 serotype-specific immunoglobulin G enzyme-linked immunosorbent assay in the seroepidemiologic study of dengue virus infection: correlation of results with those of the plaque reduction neutralization test
  publication-title: J. Clin. Microbiol.
– volume: 8
  start-page: e64056
  year: 2013
  ident: bib0189
  article-title: Underreporting of Dengue-4 in Brazil due to low sensitivity of the NS1 Ag test in routine control programs
  publication-title: PLoS ONE
– volume: 7
  year: 2016
  ident: bib0248
  article-title: Neutralization mechanism of a highly potent antibody against Zika virus
  publication-title: Nat. Commun.
– volume: 8
  year: 2012
  ident: bib0012
  article-title: Structural basis of differential neutralization of DENV-1 genotypes by an antibody that recognizes a cryptic epitope
  publication-title: PLoS Pathog.
– volume: 19
  start-page: 1189
  year: 2018
  end-page: 1198
  ident: bib0030
  article-title: The immune response against flaviviruses
  publication-title: Nat. Immunol.
– start-page: 1
  year: 2020
  end-page: 11
  ident: bib0092
  article-title: Coronavirus disease of 2019: a mimicker of Dengue infection?
  publication-title: SN Compr. Clin. Med.
– volume: 57
  start-page: 15
  year: 2013
  end-page: 25
  ident: bib0028
  article-title: A novel inhibitor of dengue virus replication that targets the capsid protein
  publication-title: Antimicrob. Agents Chemother.
– volume: 88
  start-page: 365
  year: 2007
  end-page: 375
  ident: bib0035
  article-title: Dengue virus (DENV) antibody-dependent enhancement of infection upregulates the production of anti-inflammatory cytokines, but suppresses anti-DENV free radical and pro-inflammatory cytokine production, in THP-1 cells
  publication-title: J. Gen. Virol.
– volume: 98
  start-page: 423
  year: 2013
  end-page: 431
  ident: bib0184
  article-title: Dengue virus neutralization and antibody-dependent enhancement activities of human monoclonal antibodies derived from dengue patients at acute phase of secondary infection
  publication-title: Antiviral Res.
– volume: 22
  start-page: 5
  year: 2004
  end-page: 6
  ident: bib0037
  article-title: Dengue haemorrhagic fever: a global challenge
  publication-title: Indian J. Med. Microbiol.
– volume: 87
  start-page: 8870
  year: 2013
  end-page: 8883
  ident: bib0103
  article-title: Role of RNA interference (RNAi) in dengue virus replication and identification of NS4B as an RNAi suppressor
  publication-title: J. Virol.
– volume: 11
  year: 2017
  ident: bib0231
  article-title: In a randomized trial, the live attenuated tetravalent dengue vaccine TV003 is well-tolerated and highly immunogenic in subjects with flavivirus exposure prior to vaccination
  publication-title: PLOS Negl. Trop. Dis.
– volume: 4
  year: 2010
  ident: bib0077
  article-title: Multi-country evaluation of the sensitivity and specificity of two commercially-available NS1 ELISA assays for dengue diagnosis
  publication-title: PLOS Negl. Trop. Dis.
– volume: 2
  year: 2014
  ident: bib0083
  article-title: Dengue antibody-dependent enhancement: knowns and unknowns
  publication-title: Microbiol. Spectr.
– volume: 3
  start-page: 767
  year: 2017
  end-page: 776
  ident: bib0182
  article-title: Surface-enhanced Raman spectroscopy-based sandwich immunoassays for multiplexed detection of Zika and Dengue viral biomarkers
  publication-title: ACS Infect. Dis.
– volume: 79
  start-page: 8004
  year: 2005
  end-page: 8013
  ident: bib0141
  article-title: Inhibition of alpha/beta interferon signaling by the NS4B protein of flaviviruses
  publication-title: J. Virol.
– volume: 59
  start-page: 141
  year: 2003
  end-page: 175
  ident: bib0177
  article-title: Antigenic structure of flavivirus proteins
  publication-title: Adv. Virus Res.
– volume: 41
  start-page: 4154
  year: 2003
  end-page: 4159
  ident: bib0109
  article-title: Detection of immune-complex-dissociated nonstructural-1 antigen in patients with acute dengue virus infections
  publication-title: J. Clin. Microbiol.
– volume: 24
  start-page: 195
  year: 2006
  end-page: 205
  ident: bib0044
  article-title: Protection against dengue type 2 virus induced in mice immunized with a DNA plasmid encoding the non-structural 1 (NS1) gene fused to the tissue plasminogen activator signal sequence
  publication-title: Vaccine
– volume: 9
  year: 2017
  ident: bib0025
  article-title: Rapid antigen tests for dengue virus serotypes and Zika virus in patient serum
  publication-title: Sci. Transl. Med.
– volume: 181
  start-page: 2
  year: 2000
  end-page: 9
  ident: bib254
  article-title: Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity
  publication-title: J. Infect. Dis.
– volume: 22
  start-page: 1399
  year: 2004
  end-page: 1408
  ident: bib0018
  article-title: Recombinant protein folding and misfolding in
  publication-title: Nat. Biotechnol.
– volume: 58
  start-page: 710
  year: 2013
  end-page: 712
  ident: bib0042
  article-title: Dengue-4 false negative results by Panbio® Dengue Early ELISA assay in Brazil
  publication-title: J. Clin. Virol.
– volume: 6
  start-page: e16059
  year: 2011
  ident: bib0050
  article-title: A broadly flavivirus cross-neutralizing monoclonal antibody that recognizes a novel epitope within the fusion loop of E protein
  publication-title: PLoS ONE
– volume: 423
  start-page: 867
  year: 2012
  end-page: 872
  ident: bib0190
  article-title: Human monoclonal antibodies to neutralize all dengue virus serotypes using lymphocytes from patients at acute phase of the secondary infection
  publication-title: Biochem. Biophys. Res. Commun.
– volume: 28
  start-page: 3269
  year: 2009
  end-page: 3276
  ident: bib0038
  article-title: Structural basis for the preferential recognition of immature flaviviruses by a fusion-loop antibody
  publication-title: EMBO J.
– volume: 8
  year: 2016
  ident: bib0241
  article-title: Identifying candidate targets of immune responses in Zika virus based on homology to epitopes in other flavivirus species
  publication-title: PLoS Curr.
– volume: 16
  start-page: 170
  year: 2015
  end-page: 177
  ident: bib0049
  article-title: A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus
  publication-title: Nat. Immunol.
– volume: 8
  year: 2012
  ident: bib0002
  article-title: DENV inhibits type I IFN production in infected cells by cleaving human STING
  publication-title: PLoS Pathog.
– volume: 6
  start-page: 29201
  year: 2016
  ident: bib0068
  article-title: Antibody-dependent enhancement of Dengue virus infection in primary human macrophages; balancing higher fusion against antiviral responses
  publication-title: Sci. Rep.
– volume: 33
  start-page: 7100
  year: 2015
  end-page: 7111
  ident: bib0075
  article-title: Development of the Sanofi Pasteur tetravalent dengue vaccine: one more step forward
  publication-title: Vaccine
– volume: 373
  start-page: 1195
  year: 2015
  end-page: 1206
  ident: bib0080
  article-title: Efficacy and long-term safety of a Dengue vaccine in regions of endemic disease
  publication-title: N. Engl. J. Med.
– volume: 437
  start-page: 764
  year: 2005
  end-page: 769
  ident: bib0151
  article-title: Structural basis of West Nile virus neutralization by a therapeutic antibody
  publication-title: Nature
– volume: 27
  start-page: 43
  year: 2008
  end-page: 48
  ident: bib0040
  article-title: The use of dengue nonstructural protein 1 antigen for the early diagnosis during the febrile stage in patients with dengue infection
  publication-title: Pediatr. Infect. Dis. J.
– volume: 174
  start-page: 8163
  year: 2005
  end-page: 8172
  ident: bib0093
  article-title: Dengue virus type 2 antagonizes IFN-alpha but not IFN-gamma antiviral effect via down-regulating Tyk2-STAT signaling in the human dendritic cell
  publication-title: J. Immunol.
– volume: 9
  start-page: e92495
  year: 2014
  ident: bib0224
  article-title: Protection against dengue virus infection in mice by administration of antibodies against modified nonstructural protein 1
  publication-title: PLoS ONE
– volume: 13
  year: 2019
  ident: bib0249
  article-title: Virulence difference of five type I dengue viruses and the intrinsic molecular mechanism
  publication-title: PLOS Negl. Trop. Dis.
– reference: .
– volume: 19
  start-page: 218
  year: 2019
  end-page: 230
  ident: bib0202
  article-title: Adaptive immune responses to primary and secondary dengue virus infections
  publication-title: Nat. Rev. Immunol.
– volume: 586
  start-page: 1032
  year: 2012
  end-page: 1037
  ident: bib0235
  article-title: The dengue virus M protein localises to the endoplasmic reticulum and forms oligomers
  publication-title: FEBS Lett.
– volume: 23
  start-page: 1396
  year: 2009
  end-page: 1405
  ident: bib252
  article-title: Changing drivers of deforestation and new opportunities for conservation
  publication-title: Conserv. Biol.
– volume: 69
  start-page: 82
  year: 2003
  end-page: 90
  ident: bib0121
  article-title: Antibodies from dengue patient sera cross-react with endothelial cells and induce damage
  publication-title: J. Med. Virol.
– volume: 18
  start-page: 4066
  year: 2018
  end-page: 4072
  ident: bib0145
  article-title: Bio-functionalized tapered multimode fiber coated with Dengue virus NS1 glycoprotein for label free detection of anti-dengue virus NS1 IgG antibody
  publication-title: IEEE Sens. J.
– volume: 319
  start-page: 1834
  year: 2008
  end-page: 1837
  ident: bib0247
  article-title: Structure of the immature dengue virus at low pH primes proteolytic maturation
  publication-title: Science
– volume: 11
  year: 2015
  ident: bib0186
  article-title: Dengue virus non-structural protein 1 modulates infectious particle production via interaction with the structural proteins
  publication-title: PLoS Pathog.
– volume: 117
  start-page: 17992
  year: 2020
  end-page: 18001
  ident: bib0239
  article-title: A cocrystal structure of dengue capsid protein in complex of inhibitor
  publication-title: Proc. Natl Acad. Sci.
– volume: 2012
  year: 2012
  ident: bib0023
  article-title: Commercial dengue rapid diagnostic tests for point-of-care application: recent evaluations and future needs?
  publication-title: J. Biomed. Biotechnol.
– volume: 187
  start-page: 424
  year: 2011
  end-page: 433
  ident: bib0013
  article-title: Binding of flavivirus nonstructural protein NS1 to C4b binding protein modulates complement activation
  publication-title: J. Immunol.
– volume: 147
  start-page: 235
  year: 2008
  end-page: 243
  ident: bib0029
  article-title: Selection of phage-displayed human antibody fragments on Dengue virus particles captured by a monoclonal antibody: application to the four serotypes
  publication-title: J. Virol. Methods
– volume: 77
  start-page: 7539
  year: 2003
  end-page: 7544
  ident: bib0206
  article-title: Antibody-dependent enhancement of Ebola virus infection
  publication-title: J. Virol.
– volume: 1062
  start-page: 241
  year: 2018
  end-page: 250
  ident: bib0175
  article-title: Understanding the human T cell response to Dengue virus
  publication-title: Adv. Exp. Med. Biol.
– volume: 9
  start-page: 921
  year: 2003
  end-page: 927
  ident: bib0136
  article-title: Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever
  publication-title: Nat. Med.
– volume: 449
  start-page: 419
  year: 2007
  end-page: 426
  ident: bib0203
  article-title: Taking dendritic cells into medicine
  publication-title: Nature
– volume: 18
  start-page: 430
  year: 2011
  end-page: 434
  ident: bib0052
  article-title: Full serotype- and group-specific NS1 capture enzyme-linked immunosorbent assay for rapid differential diagnosis of dengue virus infection
  publication-title: Clin. Vaccine Immunol.
– volume: 19
  start-page: 500
  year: 1994
  end-page: 512
  ident: bib0138
  article-title: Antibody-dependent enhancement of infection and the pathogenesis of viral disease
  publication-title: Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am.
– volume: 87
  start-page: 6150
  year: 2015
  end-page: 6157
  ident: bib0172
  article-title: Improved immunoassay sensitivity in serum as a result of polymer-entrapped quantum dots: 'Papaya particles'
  publication-title: Anal. Chem.
– volume: 104
  start-page: 293
  year: 2004
  end-page: 346
  ident: bib0048
  article-title: Gold nanoparticles: assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnology
  publication-title: Chem. Rev.
– volume: 17
  start-page: 615
  year: 2017
  end-page: 625
  ident: bib0180
  article-title: Safety and immunogenicity of one versus two doses of Takeda's tetravalent dengue vaccine in children in Asia and Latin America: interim results from a phase 2, randomised, placebo-controlled study
  publication-title: Lancet Infect. Dis.
– volume: 33
  start-page: 7126
  year: 2015
  end-page: 7134
  ident: bib0127
  article-title: Preclinical and clinical development of a dengue recombinant subunit vaccine
  publication-title: Vaccine
– volume: 84
  start-page: 12549
  year: 2010
  end-page: 12554
  ident: bib0187
  article-title: Peptide inhibitors of flavivirus entry derived from the E protein stem
  publication-title: J. Virol.
– volume: 14
  start-page: 1452
  year: 2022
  ident: bib0166
  article-title: Combination of E- and NS1-derived DNA vaccines: the immune response and protection elicited in mice against DENV2
  publication-title: Viruses
– volume: 352
  start-page: 467
  year: 2016
  end-page: 470
  ident: bib0199
  article-title: The 3.8 Å resolution cryo-EM structure of Zika virus
  publication-title: Science
– volume: 10
  year: 2020
  ident: bib0147
  article-title: Intrinsic ADE: the dark side of antibody dependent enhancement during Dengue infection
  publication-title: Front. Cell Infect. Microbiol.
– volume: 7
  start-page: e50995
  year: 2012
  ident: bib0124
  article-title: Release of dengue virus genome induced by a peptide inhibitor
  publication-title: PLoS ONE
– volume: 101
  start-page: 925
  year: 2006
  end-page: 928
  ident: bib0011
  article-title: Concurrent infection with dengue virus type-2 and DENV-3 in a patient from Ceará, Brazil
  publication-title: Mem. Inst. Oswaldo Cruz.
– volume: 16
  start-page: 3185
  year: 2010
  end-page: 3203
  ident: bib0069
  article-title: Chemical modifications designed to improve peptide stability: incorporation of non-natural amino acids, pseudo-peptide bonds, and cyclization
  publication-title: Curr. Pharm. Des.
– volume: 60
  start-page: 387
  year: 2008
  end-page: 391
  ident: bib0116
  article-title: Evaluation of an NS1 antigen detection for diagnosis of acute dengue infection in patients with acute febrile illness
  publication-title: Diagn. Microbiol. Infect. Dis.
– volume: 2
  start-page: 66
  year: 2013
  end-page: 81
  ident: bib0073
  article-title: Shark variable new antigen receptor (V
  publication-title: Antibodies
– volume: 24
  start-page: 203
  year: 2002
  end-page: 209
  ident: bib0242
  article-title: Virus isolation as one of the diagnostic methods for dengue virus infection
  publication-title: J. Clin. Virol.
– volume: 5
  year: 2015
  ident: bib0010
  article-title: Quantification of NS1 dengue biomarker in serum via optomagnetic nanocluster detection
  publication-title: Sci. Rep.
– year: 2020
  ident: bib0079
  article-title: ModiBodies: a computational method for modifying nanobodies in nanobody-antigen complexes to improve binding affinity and specificity
  publication-title: J. Biol. Phys.
– volume: 9
  start-page: 1354
  year: 2020
  end-page: 1355
  ident: bib0170
  article-title: Nurse infected with Covid-19 from a provisional dengue patient
  publication-title: Emerg. Microbes Infect.
– volume: 14
  start-page: 1232
  year: 2008
  end-page: 1239
  ident: bib0115
  article-title: Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007
  publication-title: Emerging Infect. Dis.
– volume: 215
  start-page: S89
  year: 2017
  end-page: s95
  ident: bib0140
  article-title: Clinical and laboratory diagnosis of Dengue virus infection
  publication-title: J. Infect. Dis.
– volume: 88
  start-page: 1897
  year: 2014
  end-page: 1913
  ident: bib0212
  article-title: Cellular vimentin regulates construction of dengue virus replication complexes through interaction with NS4A protein
  publication-title: J. Virol.
– volume: 42
  start-page: 465
  year: 1964
  end-page: 482
  ident: bib0090
  article-title: Enhancement of the infectivity of arboviruses by specific antisera produced in domestic fowls
  publication-title: Aust. J. Exp. Biol. Med. Sci.
– volume: 386
  start-page: 243
  year: 2015
  end-page: 244
  ident: bib0143
  article-title: Zika virus: following the path of Dengue and Chikungunya?
  publication-title: Lancet
– volume: 7
  year: 2017
  ident: bib0070
  article-title: Prior exposure to Zika virus significantly enhances peak Dengue-2 viremia in rhesus macaques
  publication-title: Sci. Rep.
– volume: 3
  start-page: e360
  year: 2009
  ident: bib0086
  article-title: Diagnostic accuracy of NS1 ELISA and lateral flow rapid tests for dengue sensitivity, specificity and relationship to viraemia and antibody responses
  publication-title: PLoS Negl. Trop. Dis.
– volume: 19
  start-page: 206
  year: 2018
  end-page: 224
  ident: bib0174
  article-title: The bright and the dark side of human antibody responses to flaviviruses: lessons for vaccine design
  publication-title: EMBO Rep.
– volume: 286
  start-page: 8961
  year: 2011
  end-page: 8976
  ident: bib0099
  article-title: Neutralization of
  publication-title: J. Biol. Chem.
– volume: 11
  start-page: 522
  year: 2005
  end-page: 530
  ident: bib0152
  article-title: Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus
  publication-title: Nat. Med.
– volume: 385
  start-page: 1414
  year: 2006
  end-page: 1420
  ident: bib0209
  article-title: A novel enhancement assay for immunochromatographic test strips using gold nanoparticles
  publication-title: Anal. Bioanal. Chem.
– volume: 8
  start-page: 1
  year: 2017
  end-page: 13
  ident: bib0238
  article-title: Single-domain antibodies as therapeutics against human viral diseases
  publication-title: Front. Immunol.
– volume: 268
  start-page: 340
  year: 2015
  end-page: 364
  ident: bib0211
  article-title: Fc receptors in antibody-dependent enhancement of viral infections
  publication-title: Immunol. Rev.
– volume: 108
  start-page: 12479
  year: 2011
  end-page: 12484
  ident: bib0034
  article-title: Ligation of Fc gamma receptor IIB inhibits antibody-dependent enhancement of dengue virus infection
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
– volume: 79
  start-page: 1223
  year: 2005
  end-page: 1231
  ident: bib0134
  article-title: Variable surface epitopes in the crystal structure of dengue virus type 3 envelope glycoprotein
  publication-title: J. Virol.
– volume: 10
  start-page: 712
  year: 2010
  end-page: 722
  ident: bib0084
  article-title: Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes
  publication-title: Lancet Infect. Dis.
– reference: Murugesan, A., & Manoharan, M. (2020). Dengue virus. Emerging and Reemerging Viral Pathogens, 281–359. doi:
– volume: 257
  start-page: 820
  year: 2018
  end-page: 828
  ident: bib0104
  article-title: Label-free Dengue E protein detection using a functionalized tapered optical fiber sensor
  publication-title: Sens. Actuators B Chem.
– volume: 64
  start-page: 153
  year: 2020
  end-page: 161
  ident: bib0074
  article-title: A synthetic peptide analog of in silico-predicted immunogenic epitope unique to dengue virus serotype 2 NS1 antigen specifically binds immunoglobulin G antibodies raised in rabbits
  publication-title: Microbiol. Immunol.
– volume: 90
  start-page: 7219
  year: 2016
  end-page: 7230
  ident: bib0091
  article-title: Dengue virus subverts host innate immunity by targeting adaptor protein MAVS
  publication-title: J. Virol.
– volume: 15
  start-page: 9823
  year: 2020
  end-page: 9857
  ident: bib0007
  article-title: A Review on the synthesis and functionalization of gold nanoparticles as a drug delivery vehicle
  publication-title: Int J Nanomed.
– volume: 479
  year: 2020
  ident: bib0089
  article-title: Normal human lymph node T follicular helper cells and germinal center B cells accessed via fine needle aspirations
  publication-title: J. Immunol. Methods
– volume: 4
  start-page: 15841
  year: 2014
  end-page: 15848
  ident: bib0185
  article-title: A dendrimer matrix for performance enhancement of evanescent wave absorption-based fiber-optic biosensors
  publication-title: RSC Adv.
– year: 2020
  ident: bib0006
  article-title: Genomic epidemiology of SARS-CoV-2 reveals multiple lineages and early spread of SARS-CoV-2 infections in Lombardy, Italy
  publication-title: medRxiv
– volume: 16
  start-page: 88
  year: 2009
  end-page: 95
  ident: bib0171
  article-title: Development of an antigen capture immunoassay based on monoclonal antibodies specific for dengue virus serotype 2 nonstructural protein 1 for early and rapid identification of dengue virus serotype 2 infections
  publication-title: Clin. Vaccine Immunol.
– volume: 496
  start-page: 504
  year: 2013
  end-page: 507
  ident: bib0022
  article-title: The global distribution and burden of dengue
  publication-title: Nature
– volume: 22
  start-page: e00927
  year: 2020
  ident: bib0108
  article-title: Dengue serology in Indonesian COVID-19 patients: coinfection or serological overlap?
  publication-title: IDCases
– volume: 71
  start-page: 67
  year: 2015
  end-page: 70
  ident: bib0144
  article-title: Discovery of fifth serotype of dengue virus (DENV-5): a new public health dilemma in dengue control
  publication-title: Med. J. Armed Forces India
– volume: 4
  start-page: 229
  year: 2008
  end-page: 238
  ident: bib0163
  article-title: Structural insights into the mechanisms of antibody-mediated neutralization of flavivirus infection: implications for vaccine development
  publication-title: Cell Host Microbe
– reference: Abrahamsson, N., Coulombier, D., Danielsson, N., Derrough, T., Domanovic, D., Jansà, J.M., Korhnan, T., Mollet, T., Sudre, B., Szegedi, E., et al. (2016). Rapid Risk Assessment. Zika virus disease epidemic: potential association with microcephaly and Guillain–Barré syndrome. Fourth update, 9 March 2016.
– volume: 11
  start-page: 42
  year: 1999
  end-page: 46
  ident: bib0149
  article-title: C1q-binding proteins and C1q receptors
  publication-title: Curr. Opin. Immunol.
– volume: 9
  year: 2017
  ident: bib0198
  article-title: Increased adaptive immune responses and proper feedback regulation protect against clinical dengue
  publication-title: Sci. Transl. Med.
– volume: 1082
  start-page: 116
  year: 2006
  end-page: 119
  ident: bib0244
  article-title: Selection of thioaptamers for diagnostics and therapeutics
  publication-title: Ann. N. Y. Acad. Sci.
– volume: 29
  start-page: 960
  year: 2011
  end-page: 968
  ident: bib0019
  article-title: Evaluation of a prototype dengue-1 DNA vaccine in a Phase 1 clinical trial
  publication-title: Vaccine
– volume: 393
  start-page: 350
  year: 2019
  end-page: 363
  ident: bib0234
  article-title: Dengue
  publication-title: Lancet
– volume: 5
  start-page: 796
  year: 2020
  end-page: 812
  ident: bib0162
  article-title: The continued threat of emerging flaviviruses
  publication-title: Nat. Microbiol.
– volume: 27
  start-page: 3586
  year: 2017
  end-page: 3590
  ident: bib0208
  article-title: Discovery of novel cyclic peptide inhibitors of dengue virus NS2B-NS3 protease with antiviral activity
  publication-title: Bioorg. Med. Chem. Lett.
– volume: 198
  start-page: 157
  year: 2009
  end-page: 174
  ident: bib0230
  article-title: Single domain antibodies: promising experimental and therapeutic tools in infection and immunity
  publication-title: Med. Microbiol. Immunol.
– volume: 385
  start-page: 453
  year: 2015
  end-page: 465
  ident: bib0076
  article-title: Dengue
  publication-title: Lancet
– volume: 195
  start-page: 1808
  year: 2007
  end-page: 1817
  ident: bib0113
  article-title: Dengue virus infects macrophages and dendritic cells in a mouse model of infection
  publication-title: J. Infect. Dis.
– volume: 98
  start-page: 1684
  year: 1996
  end-page: 1691
  ident: bib0132
  article-title: Dominant recognition by human CD8+ cytotoxic T lymphocytes of dengue virus nonstructural proteins NS3 and NS1.2a
  publication-title: J. Clin. Invest.
– volume: 15
  start-page: 2295
  year: 2019
  end-page: 2314
  ident: bib0214
  article-title: A review of Dengvaxia®: development to deployment
  publication-title: Hum. Vaccin. Immunother.
– volume: 52
  start-page: 855
  year: 2013
  end-page: 868
  ident: bib0051
  article-title: Pharmacokinetics and pharmacokinetic-pharmacodynamic correlations of therapeutic peptides
  publication-title: Clin. Pharmacokinet.
– reference: WHO. (2009). Dengue guidelines for diagnosis, treatment, prevention and control: new edition.
– volume: 1
  start-page: 747
  year: 2013
  end-page: 794
  ident: bib0161
  article-title: Flaviviruses
  publication-title: Firlds Virol.
– volume: 101
  start-page: 3414
  year: 2004
  end-page: 3419
  ident: bib0126
  article-title: Solution structure of dengue virus capsid protein reveals another fold
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
– volume: 197
  start-page: 4053
  year: 2016
  end-page: 4065
  ident: bib0213
  article-title: Secreted NS1 protects Dengue virus from mannose binding lectin-mediated neutralization
  publication-title: J. Immunol.
– volume: 8
  start-page: e61232
  year: 2013
  ident: bib0192
  article-title: Ebolavirus nucleoprotein C-termini potently attract single domain antibodies enabling monoclonal affinity reagent sandwich assay (MARSA) formulation
  publication-title: PLoS ONE
– volume: 10
  start-page: 317
  year: 2003
  end-page: 322
  ident: bib0017
  article-title: Diagnosis of dengue virus infection by detection of specific immunoglobulin M (IgM) and IgA antibodies in serum and saliva
  publication-title: Clin. Diagn. Lab. Immunol.
– volume: 18
  start-page: E8
  year: 2012
  end-page: 10
  ident: bib0071
  article-title: Evaluation and use of NS1 IgM antibody detection for acute dengue virus diagnosis: report from an outbreak investigation
  publication-title: Clin. Microbiol. Infect.
– volume: 9
  start-page: 13483
  year: 2019
  ident: bib0146
  article-title: Detection of dengue using PAMAM dendrimer integrated tapered optical fiber sensor
  publication-title: Sci. Rep.
– volume: 55
  start-page: e45
  year: 2012
  end-page: e53
  ident: bib0032
  article-title: Recent introduction and rapid dissemination of Chikungunya virus and Dengue virus serotype 2 associated with human and mosquito coinfections in Gabon, central Africa
  publication-title: Clin. Infect. Dis.
– volume: 7
  start-page: 361
  year: 2010
  ident: bib0153
  article-title: Comparison of the diagnostic accuracy of commercial NS1-based diagnostic tests for early dengue infection
  publication-title: Virol. J.
– volume: 83
  start-page: 690
  year: 2010
  end-page: 695
  ident: bib0226
  article-title: Early diagnosis of Dengue infection using a commercial Dengue Duo rapid test kit for the detection of NS1, IgM, and IgG
  publication-title: Am. J. Trop. Med. Hyg.
– volume: 4
  start-page: 383
  year: 1997
  end-page: 386
  ident: bib0220
  article-title: Detection of antibodies to hepatitis C virus in seronegative patients using an immune complex dissociation assay
  publication-title: J. Viral Hepat.
– volume: 89
  start-page: 7170
  year: 2015
  end-page: 7186
  ident: bib0036
  article-title: A combined genetic-proteomic approach identifies residues within Dengue virus NS4B critical for interaction with NS3 and viral replication
  publication-title: J. Virol.
– volume: 2
  start-page: 49
  year: 2005
  ident: bib0096
  article-title: Peptide inhibitors of dengue virus and West Nile virus infectivity
  publication-title: Virol. J.
– volume: 427
  start-page: 313
  year: 2004
  end-page: 319
  ident: bib0133
  article-title: Structure of the dengue virus envelope protein after membrane fusion
  publication-title: Nature
– volume: 4
  start-page: e08347
  year: 2015
  ident: bib0111
  article-title: The global distribution of the arbovirus vectors
  publication-title: Elife
– volume: 14
  year: 2022
  ident: bib0128
  article-title: Current understanding of the role of T cells in Chikungunya, Dengue and Zika infections
  publication-title: Viruses
– volume: 6
  start-page: e1993
  year: 2012
  ident: bib0009
  article-title: Field evaluation and impact on clinical management of a rapid diagnostic kit that detects dengue NS1, IgM and IgG
  publication-title: PLOS Negl. Trop. Dis.
– reference: 11(6), 429–433. doi:
– volume: 11
  start-page: 479
  year: 2020
  ident: bib0072
  article-title: Rapid induction and maintenance of virus-specific CD8
  publication-title: Front. Immunol.
– volume: 6
  start-page: 6341
  year: 2015
  ident: bib0066
  article-title: A highly potent human antibody neutralizes dengue virus serotype 3 by binding across three surface proteins
  publication-title: Nat. Commun.
– volume: 2
  year: 2002
  ident: bib0031
  article-title: Antibodies against prM protein distinguish between previous infection with dengue and Japanese encephalitis viruses
  publication-title: BMC Microbiol.
– volume: 299
  start-page: 130
  year: 2010
  end-page: 136
  ident: bib0110
  article-title: A bispecific antibody effectively inhibits tumor growth and metastasis by simultaneous blocking vascular endothelial growth factor A and osteopontin
  publication-title: Cancer Lett.
– volume: 86
  start-page: 7360
  year: 2012
  end-page: 7371
  ident: bib0246
  article-title: Evidence for a genetic and physical interaction between nonstructural proteins NS1 and NS4B that modulates replication of West Nile virus
  publication-title: J. Virol.
– volume: 80
  start-page: 2170
  year: 2006
  end-page: 2182
  ident: bib0041
  article-title: RNA secondary structure in the coding region of dengue virus type 2 directs translation start codon selection and is required for viral replication
  publication-title: J. Virol.
– volume: 63
  start-page: 140
  year: 2020
  end-page: 156
  ident: bib0055
  article-title: Peptide-β-lactam inhibitors of Dengue and West Nile virus NS2B-NS3 protease display two distinct binding modes
  publication-title: J. Med. Chem.
– volume: 19
  start-page: 1972
  year: 2012
  end-page: 1976
  ident: bib0062
  article-title: Low sensitivity of NS1 protein tests evidenced during a dengue type 2 virus outbreak in Santos, Brazil, in 2010
  publication-title: Clin. Vaccine Immunol.
– volume: 2019
  year: 2019
  ident: bib0137
  article-title: Cross-reaction, enhancement, and neutralization activity of Dengue virus antibodies against Zika virus: a study in the Mexican population
  publication-title: J. Immunol. Res.
– volume: 260
  start-page: 109
  year: 2001
  end-page: 143
  ident: bib0026
  article-title: A model for neutralization of viruses based on antibody coating of the virion surface
  publication-title: Curr. Top. Microbiol. Immunol.
– volume: 11
  start-page: 369
  year: 2008
  end-page: 377
  ident: bib0160
  article-title: Structural proteomics of dengue virus
  publication-title: Curr. Opin. Microbiol.
– volume: 319
  start-page: 1830
  year: 2008
  end-page: 1834
  ident: bib0118
  article-title: The flavivirus precursor membrane-envelope protein complex: structure and maturation
  publication-title: Science
– volume: 31
  start-page: e2161
  year: 2021
  ident: bib0087
  article-title: Covid-19 and dengue: double punches for dengue-endemic countries in Asia
  publication-title: Rev. Med. Virol.
– volume: 100
  start-page: 6986
  year: 2003
  end-page: 6991
  ident: bib251
  article-title: A ligand-binding pocket in the dengue virus envelope glycoprotein
  publication-title: Proc. Natl. Acad. Sci. USA
– volume: 8
  start-page: S30
  year: 2010
  end-page: S38
  ident: bib0159
  article-title: Evaluation of diagnostic tests: dengue
  publication-title: Nat. Rev. Microbiol.
– volume: 59
  start-page: 60
  year: 2018
  ident: bib0102
  article-title: Comment on: definitive tests for dengue fever: when and which should I use?
  publication-title: Singapore Med. J.
– volume: 42
  start-page: 350
  year: 1970
  end-page: 362
  ident: bib0081
  article-title: Observations related to pathogensis of dengue hemorrhagic fever. VI. Hypotheses and discussion
  publication-title: Yale J. Biol. Med.
– volume: 53
  start-page: 1092
  year: 2015
  end-page: 1102
  ident: bib0155
  article-title: Multicountry prospective clinical evaluation of two enzyme-linked immunosorbent assays and two rapid diagnostic tests for diagnosing dengue fever
  publication-title: J. Clin. Microbiol.
– volume: 12
  year: 2017
  ident: bib0117
  article-title: Isolation of serotype-specific antibodies against dengue virus non-structural protein 1 using phage display and application in a multiplexed serotyping assay
  publication-title: PLoS ONE
– volume: 9
  year: 2011
  ident: bib0067
  article-title: A case of convergence: why did a simple alternative to canonical antibodies arise in sharks and camels?
  publication-title: PLoS Biol.
– volume: 40
  start-page: 376
  year: 2002
  end-page: 381
  ident: bib0005
  article-title: Enzyme-linked immunosorbent assay specific to Dengue virus type 1 nonstructural protein NS1 reveals circulation of the antigen in the blood during the acute phase of disease in patients experiencing primary or secondary infections
  publication-title: J. Clin. Microbiol.
– volume: 6
  start-page: 28768
  year: 2016
  ident: bib0015
  article-title: How antibodies alter the cell entry pathway of dengue virus particles in macrophages
  publication-title: Sci. Rep.
– volume: 45
  start-page: 11
  year: 2003
  end-page: 16
  ident: bib0054
  article-title: Molecular characterization of dengue viruses type 1 and 2 isolated from a concurrent human infection
  publication-title: Rev. Inst. Med. Trop. Sao Paulo
– volume: 142
  year: 2021
  ident: bib0095
  article-title: Review of antiviral peptides for use against zoonotic and selected non-zoonotic viruses
  publication-title: Peptides
– reference: Halstead, S.B. (1980). 5 - Immunological parameters of togavirus disease syndromes. The Togaviruses, 107–173. doi:
– volume: 80
  start-page: 6295
  year: 2006
  end-page: 6304
  ident: bib0065
  article-title: Influenza virus evades innate and adaptive immunity via the NS1 protein
  publication-title: J. Virol.
– volume: 13
  start-page: 1185
  year: 2006
  end-page: 1189
  ident: bib0057
  article-title: Evaluation of an enzyme immunoassay for detection of dengue virus NS1 antigen in human serum
  publication-title: Clin. Vaccine Immunol.
– volume: 138
  start-page: 1619
  year: 2013
  end-page: 1627
  ident: bib0218
  article-title: Antibody orientation on biosensor surfaces: a minireview
  publication-title: Analyst
– volume: 20
  start-page: 536
  year: 2020
  ident: bib0243
  article-title: Covert COVID-19 and false-positive dengue serology in Singapore
  publication-title: Lancet Infect. Dis.
– volume: 108
  start-page: 9190
  year: 2011
  end-page: 9195
  ident: bib0201
  article-title: Immune surveillance by mast cells during dengue infection promotes natural killer (NK) and NKT-cell recruitment and viral clearance
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
– volume: 91
  start-page: 2395
  year: 1994
  end-page: 2400
  ident: bib0135
  article-title: Dengue: the risk to developed and developing countries
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
– volume: 7
  year: 2019
  ident: bib0216
  article-title: The interplay between Dengue virus and the human innate immune system: a game of hide and seek
  publication-title: Vaccines
– volume: 12
  start-page: e1584
  year: 2020
  ident: bib0167
  article-title: Single and multiple detections of foodborne pathogens by gold nanoparticle assays
  publication-title: Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol.
– volume: 5
  start-page: 365
  year: 2009
  end-page: 375
  ident: bib0228
  article-title: Composition and three-dimensional architecture of the dengue virus replication and assembly sites
  publication-title: Cell Host Microbe
– volume: 15
  start-page: 436
  year: 2009
  end-page: 440
  ident: bib0098
  article-title: Evaluation of commercially available anti-dengue virus immunoglobulin M tests
  publication-title: Emerg. Infect. Dis.
– volume: 8
  start-page: 653
  year: 2017
  ident: bib0063
  article-title: Camelid single-domain antibodies as an alternative to overcome challenges related to the prevention, detection, and control of neglected tropical diseases
  publication-title: Front. Immunol.
– volume: 3
  start-page: 263
  issue: 1
  year: 2016
  ident: 10.1016/j.virusres.2022.199018_bib0027
  article-title: Properties and functions of the Dengue virus capsid protein
  publication-title: Annu. Rev. Virol.
  doi: 10.1146/annurev-virology-110615-042334
– volume: 44
  start-page: 2872
  issue: 8
  year: 2006
  ident: 10.1016/j.virusres.2022.199018_bib0240
  article-title: Serotype 1-specific monoclonal antibody-based antigen capture immunoassay for detection of circulating nonstructural protein NS1: implications for early diagnosis and serotyping of dengue virus infections
  publication-title: J. Clin. Microbiol.
  doi: 10.1128/JCM.00777-06
– volume: 64
  start-page: 2853
  issue: 8
  year: 2004
  ident: 10.1016/j.virusres.2022.199018_bib0043
  article-title: Efficient cancer therapy with a nanobody-based conjugate
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-03-3935
– volume: 427
  start-page: 313
  issue: 6972
  year: 2004
  ident: 10.1016/j.virusres.2022.199018_bib0133
  article-title: Structure of the dengue virus envelope protein after membrane fusion
  publication-title: Nature
  doi: 10.1038/nature02165
– volume: 8
  start-page: 653
  year: 2017
  ident: 10.1016/j.virusres.2022.199018_bib0063
  article-title: Camelid single-domain antibodies as an alternative to overcome challenges related to the prevention, detection, and control of neglected tropical diseases
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2017.00653
– volume: 4
  issue: 8
  year: 2010
  ident: 10.1016/j.virusres.2022.199018_bib0077
  article-title: Multi-country evaluation of the sensitivity and specificity of two commercially-available NS1 ELISA assays for dengue diagnosis
  publication-title: PLOS Negl. Trop. Dis.
  doi: 10.1371/journal.pntd.0000811
– volume: 6
  start-page: 28768
  year: 2016
  ident: 10.1016/j.virusres.2022.199018_bib0015
  article-title: How antibodies alter the cell entry pathway of dengue virus particles in macrophages
  publication-title: Sci. Rep.
  doi: 10.1038/srep28768
– volume: 88
  start-page: 365
  issue: Pt 2
  year: 2007
  ident: 10.1016/j.virusres.2022.199018_bib0035
  article-title: Dengue virus (DENV) antibody-dependent enhancement of infection upregulates the production of anti-inflammatory cytokines, but suppresses anti-DENV free radical and pro-inflammatory cytokine production, in THP-1 cells
  publication-title: J. Gen. Virol.
  doi: 10.1099/vir.0.82537-0
– volume: 89
  start-page: 7170
  issue: 14
  year: 2015
  ident: 10.1016/j.virusres.2022.199018_bib0036
  article-title: A combined genetic-proteomic approach identifies residues within Dengue virus NS4B critical for interaction with NS3 and viral replication
  publication-title: J. Virol.
  doi: 10.1128/JVI.00867-15
– volume: 2
  issue: 6
  year: 2014
  ident: 10.1016/j.virusres.2022.199018_bib0083
  article-title: Dengue antibody-dependent enhancement: knowns and unknowns
  publication-title: Microbiol. Spectr.
  doi: 10.1128/microbiolspec.AID-0022-2014
– volume: 88
  start-page: 1897
  issue: 4
  year: 2014
  ident: 10.1016/j.virusres.2022.199018_bib0212
  article-title: Cellular vimentin regulates construction of dengue virus replication complexes through interaction with NS4A protein
  publication-title: J. Virol.
  doi: 10.1128/JVI.01249-13
– volume: 197
  start-page: 4053
  issue: 10
  year: 2016
  ident: 10.1016/j.virusres.2022.199018_bib0213
  article-title: Secreted NS1 protects Dengue virus from mannose binding lectin-mediated neutralization
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.1600323
– volume: 268
  start-page: 340
  issue: 1
  year: 2015
  ident: 10.1016/j.virusres.2022.199018_bib0211
  article-title: Fc receptors in antibody-dependent enhancement of viral infections
  publication-title: Immunol. Rev.
  doi: 10.1111/imr.12367
– volume: 10
  start-page: 712
  issue: 10
  year: 2010
  ident: 10.1016/j.virusres.2022.199018_bib0084
  article-title: Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes
  publication-title: Lancet Infect. Dis.
  doi: 10.1016/S1473-3099(10)70166-3
– volume: 87
  start-page: 6150
  issue: 12
  year: 2015
  ident: 10.1016/j.virusres.2022.199018_bib0172
  article-title: Improved immunoassay sensitivity in serum as a result of polymer-entrapped quantum dots: 'Papaya particles'
  publication-title: Anal. Chem.
  doi: 10.1021/acs.analchem.5b00762
– volume: 7
  year: 2017
  ident: 10.1016/j.virusres.2022.199018_bib0070
  article-title: Prior exposure to Zika virus significantly enhances peak Dengue-2 viremia in rhesus macaques
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-017-10901-1
– volume: 1
  start-page: 135
  issue: 2
  year: 2007
  ident: 10.1016/j.virusres.2022.199018_bib0164
  article-title: The stoichiometry of antibody-mediated neutralization and enhancement of West Nile virus infection
  publication-title: Cell Host Microbe
  doi: 10.1016/j.chom.2007.03.002
– volume: 7
  start-page: e50995
  issue: 11
  year: 2012
  ident: 10.1016/j.virusres.2022.199018_bib0124
  article-title: Release of dengue virus genome induced by a peptide inhibitor
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0050995
– volume: 21
  start-page: 381
  issue: 2
  year: 2015
  ident: 10.1016/j.virusres.2022.199018_bib0056
  article-title: Co-infection with Zika and dengue viruses in 2 patients, New Caledonia, 2014
  publication-title: Emerg. Infect. Dis.
  doi: 10.3201/eid2102.141553
– volume: 4
  start-page: 383
  issue: 6
  year: 1997
  ident: 10.1016/j.virusres.2022.199018_bib0220
  article-title: Detection of antibodies to hepatitis C virus in seronegative patients using an immune complex dissociation assay
  publication-title: J. Viral Hepat.
  doi: 10.1046/j.1365-2893.1997.00068.x
– volume: 19
  start-page: 1189
  year: 2018
  ident: 10.1016/j.virusres.2022.199018_bib0030
  article-title: The immune response against flaviviruses
  publication-title: Nat. Immunol.
  doi: 10.1038/s41590-018-0210-3
– volume: 1
  start-page: 747
  year: 2013
  ident: 10.1016/j.virusres.2022.199018_bib0161
  article-title: Flaviviruses
  publication-title: Firlds Virol.
– volume: 373
  start-page: 1195
  issue: 13
  year: 2015
  ident: 10.1016/j.virusres.2022.199018_bib0080
  article-title: Efficacy and long-term safety of a Dengue vaccine in regions of endemic disease
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa1506223
– volume: 437
  start-page: 764
  issue: 7059
  year: 2005
  ident: 10.1016/j.virusres.2022.199018_bib0151
  article-title: Structural basis of West Nile virus neutralization by a therapeutic antibody
  publication-title: Nature
  doi: 10.1038/nature03956
– volume: 14
  issue: 2
  year: 2022
  ident: 10.1016/j.virusres.2022.199018_bib0128
  article-title: Current understanding of the role of T cells in Chikungunya, Dengue and Zika infections
  publication-title: Viruses
  doi: 10.3390/v14020242
– volume: 90
  start-page: 7219
  issue: 16
  year: 2016
  ident: 10.1016/j.virusres.2022.199018_bib0091
  article-title: Dengue virus subverts host innate immunity by targeting adaptor protein MAVS
  publication-title: J. Virol.
  doi: 10.1128/JVI.00221-16
– volume: 146
  start-page: 201
  issue: 1
  year: 1977
  ident: 10.1016/j.virusres.2022.199018_bib0085
  article-title: Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.146.1.201
– volume: 28
  start-page: 3269
  issue: 20
  year: 2009
  ident: 10.1016/j.virusres.2022.199018_bib0038
  article-title: Structural basis for the preferential recognition of immature flaviviruses by a fusion-loop antibody
  publication-title: EMBO J.
  doi: 10.1038/emboj.2009.245
– volume: 55
  start-page: e45
  issue: 6
  year: 2012
  ident: 10.1016/j.virusres.2022.199018_bib0032
  article-title: Recent introduction and rapid dissemination of Chikungunya virus and Dengue virus serotype 2 associated with human and mosquito coinfections in Gabon, central Africa
  publication-title: Clin. Infect. Dis.
  doi: 10.1093/cid/cis530
– volume: 343
  start-page: 678
  issue: 8898
  year: 1994
  ident: 10.1016/j.virusres.2022.199018_bib0105
  article-title: Dengue serotypes 2 and 3 in US forces in Somalia
  publication-title: Lancet
  doi: 10.1016/S0140-6736(94)92678-6
– volume: 11
  start-page: 528
  issue: 5
  year: 2012
  ident: 10.1016/j.virusres.2022.199018_bib0122
  article-title: The mitochondrial targeting chaperone 14-3-3ε regulates a RIG-I translocon that mediates membrane association and innate antiviral immunity
  publication-title: Cell Host Microbe
  doi: 10.1016/j.chom.2012.04.006
– volume: 5
  start-page: 796
  issue: 6
  year: 2020
  ident: 10.1016/j.virusres.2022.199018_bib0162
  article-title: The continued threat of emerging flaviviruses
  publication-title: Nat. Microbiol.
  doi: 10.1038/s41564-020-0714-0
– volume: 59
  start-page: 60
  issue: 1
  year: 2018
  ident: 10.1016/j.virusres.2022.199018_bib0102
  article-title: Comment on: definitive tests for dengue fever: when and which should I use?
  publication-title: Singapore Med. J.
  doi: 10.11622/smedj.2018008
– volume: 51
  start-page: 194
  issue: 3
  year: 2014
  ident: 10.1016/j.virusres.2022.199018_bib0003
  article-title: Comparison of NS1 antigen detection ELISA, real time RT-PCR and virus isolation for rapid diagnosis of dengue infection in acute phase
  publication-title: J. Vector Borne Dis.
  doi: 10.4103/0972-9062.141759
– volume: 26
  start-page: I100
  issue: Suppl 8
  year: 2008
  ident: 10.1016/j.virusres.2022.199018_bib0014
  article-title: Complement and its role in protection and pathogenesis of flavivirus infections
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2008.11.061
– volume: 14
  start-page: 570
  year: 2014
  ident: 10.1016/j.virusres.2022.199018_bib0158
  article-title: Dengue NS1 antigen as a marker of severe clinical disease
  publication-title: BMC Infect. Dis.
  doi: 10.1186/s12879-014-0570-8
– volume: 86
  start-page: 1093
  issue: 5
  year: 2015
  ident: 10.1016/j.virusres.2022.199018_bib0157
  article-title: A peptide inhibitor derived from the conserved ectodomain region of DENV membrane (M) protein with activity against dengue virus infection
  publication-title: Chem. Biol. Drug Des.
  doi: 10.1111/cbdd.12576
– volume: 5
  start-page: 365
  issue: 4
  year: 2009
  ident: 10.1016/j.virusres.2022.199018_bib0228
  article-title: Composition and three-dimensional architecture of the dengue virus replication and assembly sites
  publication-title: Cell Host Microbe
  doi: 10.1016/j.chom.2009.03.007
– volume: 8
  start-page: e61232
  issue: 4
  year: 2013
  ident: 10.1016/j.virusres.2022.199018_bib0192
  article-title: Ebolavirus nucleoprotein C-termini potently attract single domain antibodies enabling monoclonal affinity reagent sandwich assay (MARSA) formulation
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0061232
– volume: 27
  start-page: 3963
  issue: 18
  year: 2019
  ident: 10.1016/j.virusres.2022.199018_bib0047
  article-title: Peptide derivatives as inhibitors of NS2B-NS3 protease from Dengue, West Nile, and Zika flaviviruses
  publication-title: Bioorg. Med. Chem.
  doi: 10.1016/j.bmc.2019.07.038
– volume: 366
  start-page: 1423
  issue: 15
  year: 2012
  ident: 10.1016/j.virusres.2022.199018_bib0197
  article-title: Dengue
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMra1110265
– volume: 198
  start-page: 157
  issue: 3
  year: 2009
  ident: 10.1016/j.virusres.2022.199018_bib0230
  article-title: Single domain antibodies: promising experimental and therapeutic tools in infection and immunity
  publication-title: Med. Microbiol. Immunol.
  doi: 10.1007/s00430-009-0116-7
– volume: 86
  start-page: 271
  year: 2011
  ident: 10.1016/j.virusres.2022.199018_bib0100
  article-title: A novel biosensor based on serum antibody immobilization for rapid detection of viral antigens
  publication-title: Talanta
  doi: 10.1016/j.talanta.2011.09.012
– volume: 84
  start-page: 12549
  issue: 24
  year: 2010
  ident: 10.1016/j.virusres.2022.199018_bib0187
  article-title: Peptide inhibitors of flavivirus entry derived from the E protein stem
  publication-title: J. Virol.
  doi: 10.1128/JVI.01440-10
– volume: 11
  issue: 5
  year: 2017
  ident: 10.1016/j.virusres.2022.199018_bib0231
  article-title: In a randomized trial, the live attenuated tetravalent dengue vaccine TV003 is well-tolerated and highly immunogenic in subjects with flavivirus exposure prior to vaccination
  publication-title: PLOS Negl. Trop. Dis.
  doi: 10.1371/journal.pntd.0005584
– volume: 80
  start-page: 6295
  issue: 13
  year: 2006
  ident: 10.1016/j.virusres.2022.199018_bib0065
  article-title: Influenza virus evades innate and adaptive immunity via the NS1 protein
  publication-title: J. Virol.
  doi: 10.1128/JVI.02381-05
– volume: 393
  start-page: 350
  issue: 10169
  year: 2019
  ident: 10.1016/j.virusres.2022.199018_bib0234
  article-title: Dengue
  publication-title: Lancet
  doi: 10.1016/S0140-6736(18)32560-1
– volume: 8
  year: 2016
  ident: 10.1016/j.virusres.2022.199018_bib0241
  article-title: Identifying candidate targets of immune responses in Zika virus based on homology to epitopes in other flavivirus species
  publication-title: PLoS Curr.
– volume: 3
  start-page: e360
  issue: 1
  year: 2009
  ident: 10.1016/j.virusres.2022.199018_bib0086
  article-title: Diagnostic accuracy of NS1 ELISA and lateral flow rapid tests for dengue sensitivity, specificity and relationship to viraemia and antibody responses
  publication-title: PLoS Negl. Trop. Dis.
  doi: 10.1371/journal.pntd.0000360
– volume: 1062
  start-page: 241
  year: 2018
  ident: 10.1016/j.virusres.2022.199018_bib0175
  article-title: Understanding the human T cell response to Dengue virus
  publication-title: Adv. Exp. Med. Biol.
  doi: 10.1007/978-981-10-8727-1_17
– volume: 175
  start-page: 1931
  issue: 7
  year: 2018
  ident: 10.1016/j.virusres.2022.199018_bib0191
  article-title: Comparative flavivirus-host protein interaction mapping reveals mechanisms of Dengue and Zika virus pathogenesis
  publication-title: Cell
  doi: 10.1016/j.cell.2018.11.028
– volume: 2012
  year: 2012
  ident: 10.1016/j.virusres.2022.199018_bib0023
  article-title: Commercial dengue rapid diagnostic tests for point-of-care application: recent evaluations and future needs?
  publication-title: J. Biomed. Biotechnol.
  doi: 10.1155/2012/151967
– volume: 8
  start-page: 18086
  issue: 1
  year: 2018
  ident: 10.1016/j.virusres.2022.199018_bib0195
  article-title: Selection and characterization of anti-dengue NS1 single domain antibodies
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-018-35923-1
– volume: 57
  start-page: 15
  issue: 1
  year: 2013
  ident: 10.1016/j.virusres.2022.199018_bib0028
  article-title: A novel inhibitor of dengue virus replication that targets the capsid protein
  publication-title: Antimicrob. Agents Chemother.
  doi: 10.1128/AAC.01429-12
– volume: 27
  start-page: 43
  issue: 1
  year: 2008
  ident: 10.1016/j.virusres.2022.199018_bib0040
  article-title: The use of dengue nonstructural protein 1 antigen for the early diagnosis during the febrile stage in patients with dengue infection
  publication-title: Pediatr. Infect. Dis. J.
  doi: 10.1097/INF.0b013e318150666d
– volume: 16
  start-page: 3185
  issue: 28
  year: 2010
  ident: 10.1016/j.virusres.2022.199018_bib0069
  article-title: Chemical modifications designed to improve peptide stability: incorporation of non-natural amino acids, pseudo-peptide bonds, and cyclization
  publication-title: Curr. Pharm. Des.
  doi: 10.2174/138161210793292555
– volume: 8
  start-page: 271
  issue: 3
  year: 2010
  ident: 10.1016/j.virusres.2022.199018_bib0020
  article-title: The human immune response to Dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity
  publication-title: Cell Host Microbe
  doi: 10.1016/j.chom.2010.08.007
– volume: 386
  start-page: 243
  issue: 9990
  year: 2015
  ident: 10.1016/j.virusres.2022.199018_bib0143
  article-title: Zika virus: following the path of Dengue and Chikungunya?
  publication-title: Lancet
  doi: 10.1016/S0140-6736(15)61273-9
– volume: 11
  start-page: 522
  issue: 5
  year: 2005
  ident: 10.1016/j.virusres.2022.199018_bib0152
  article-title: Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus
  publication-title: Nat. Med.
  doi: 10.1038/nm1240
– volume: 11
  issue: 11
  year: 2015
  ident: 10.1016/j.virusres.2022.199018_bib0186
  article-title: Dengue virus non-structural protein 1 modulates infectious particle production via interaction with the structural proteins
  publication-title: PLoS Pathog.
  doi: 10.1371/journal.ppat.1005277
– volume: 375
  start-page: 291
  issue: 6529
  year: 1995
  ident: 10.1016/j.virusres.2022.199018_bib0173
  article-title: The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution
  publication-title: Nature
  doi: 10.1038/375291a0
– volume: 32
  start-page: 194
  issue: 3
  year: 2005
  ident: 10.1016/j.virusres.2022.199018_bib0229
  article-title: Simultaneous infection with dengue 2 and 3 viruses in a Chinese patient return from Sri Lanka
  publication-title: J. Clin. Virol.
  doi: 10.1016/j.jcv.2004.04.010
– volume: 257
  start-page: 62
  year: 2018
  ident: 10.1016/j.virusres.2022.199018_bib0148
  article-title: Development of antibody biomarkers of long term and recent dengue virus infections
  publication-title: J. Virol. Methods
  doi: 10.1016/j.jviromet.2018.04.009
– volume: 77
  start-page: 7539
  issue: 13
  year: 2003
  ident: 10.1016/j.virusres.2022.199018_bib0206
  article-title: Antibody-dependent enhancement of Ebola virus infection
  publication-title: J. Virol.
  doi: 10.1128/JVI.77.13.7539-7544.2003
– volume: 13
  start-page: 1185
  issue: 11
  year: 2006
  ident: 10.1016/j.virusres.2022.199018_bib0057
  article-title: Evaluation of an enzyme immunoassay for detection of dengue virus NS1 antigen in human serum
  publication-title: Clin. Vaccine Immunol.
  doi: 10.1128/CVI.00229-06
– volume: 13
  issue: 7
  year: 2021
  ident: 10.1016/j.virusres.2022.199018_bib0112
  article-title: Dengue and the lectin pathway of the complement system
  publication-title: Viruses
  doi: 10.3390/v13071219
– volume: 14
  start-page: 1232
  year: 2008
  ident: 10.1016/j.virusres.2022.199018_bib0115
  article-title: Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007
  publication-title: Emerging Infect. Dis.
  doi: 10.3201/eid1408.080287
– volume: 9
  issue: 11
  year: 2014
  ident: 10.1016/j.virusres.2022.199018_bib0154
  article-title: Evaluation of dengue NS1 antigen rapid tests and ELISA kits using clinical samples
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0113411
– volume: 91
  start-page: 9424
  issue: 15
  year: 2019
  ident: 10.1016/j.virusres.2022.199018_bib0008
  article-title: Oriented immobilization of single-domain antibodies using SpyTag/SpyCatcher yields improved limits of detection
  publication-title: Anal. Chem.
  doi: 10.1021/acs.analchem.9b02096
– volume: 257
  start-page: 820
  year: 2018
  ident: 10.1016/j.virusres.2022.199018_bib0104
  article-title: Label-free Dengue E protein detection using a functionalized tapered optical fiber sensor
  publication-title: Sens. Actuators B Chem.
  doi: 10.1016/j.snb.2017.11.005
– volume: 18
  start-page: 4066
  year: 2018
  ident: 10.1016/j.virusres.2022.199018_bib0145
  article-title: Bio-functionalized tapered multimode fiber coated with Dengue virus NS1 glycoprotein for label free detection of anti-dengue virus NS1 IgG antibody
  publication-title: IEEE Sens. J.
  doi: 10.1109/JSEN.2018.2813385
– volume: 75
  start-page: 7769
  issue: 16
  year: 2001
  ident: 10.1016/j.virusres.2022.199018_bib0045
  article-title: Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells
  publication-title: J. Virol.
  doi: 10.1128/JVI.75.16.7769-7773.2001
– volume: 42
  start-page: 350
  issue: 5
  year: 1970
  ident: 10.1016/j.virusres.2022.199018_bib0081
  article-title: Observations related to pathogensis of dengue hemorrhagic fever. VI. Hypotheses and discussion
  publication-title: Yale J. Biol. Med.
– volume: 8
  issue: 10
  year: 2012
  ident: 10.1016/j.virusres.2022.199018_bib0012
  article-title: Structural basis of differential neutralization of DENV-1 genotypes by an antibody that recognizes a cryptic epitope
  publication-title: PLoS Pathog.
  doi: 10.1371/journal.ppat.1002930
– ident: 10.1016/j.virusres.2022.199018_bib0233
– volume: 15
  start-page: 9823
  year: 2020
  ident: 10.1016/j.virusres.2022.199018_bib0007
  article-title: A Review on the synthesis and functionalization of gold nanoparticles as a drug delivery vehicle
  publication-title: Int J Nanomed.
  doi: 10.2147/IJN.S279094
– volume: 6
  start-page: 29201
  year: 2016
  ident: 10.1016/j.virusres.2022.199018_bib0068
  article-title: Antibody-dependent enhancement of Dengue virus infection in primary human macrophages; balancing higher fusion against antiviral responses
  publication-title: Sci. Rep.
  doi: 10.1038/srep29201
– volume: 10
  start-page: 12933
  issue: 1
  year: 2020
  ident: 10.1016/j.virusres.2022.199018_bib0200
  article-title: Peptides targeting dengue viral nonstructural protein 1 inhibit dengue virus production
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-020-69515-9
– volume: 1082
  start-page: 116
  year: 2006
  ident: 10.1016/j.virusres.2022.199018_bib0244
  article-title: Selection of thioaptamers for diagnostics and therapeutics
  publication-title: Ann. N. Y. Acad. Sci.
  doi: 10.1196/annals.1348.065
– volume: 11
  start-page: 369
  issue: 4
  year: 2008
  ident: 10.1016/j.virusres.2022.199018_bib0160
  article-title: Structural proteomics of dengue virus
  publication-title: Curr. Opin. Microbiol.
  doi: 10.1016/j.mib.2008.06.004
– volume: 101
  start-page: 3414
  issue: 10
  year: 2004
  ident: 10.1016/j.virusres.2022.199018_bib0126
  article-title: Solution structure of dengue virus capsid protein reveals another fold
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.0305892101
– volume: 24
  start-page: 195
  issue: 2
  year: 2006
  ident: 10.1016/j.virusres.2022.199018_bib0044
  article-title: Protection against dengue type 2 virus induced in mice immunized with a DNA plasmid encoding the non-structural 1 (NS1) gene fused to the tissue plasminogen activator signal sequence
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2005.07.059
– volume: 2
  start-page: 66
  year: 2013
  ident: 10.1016/j.virusres.2022.199018_bib0073
  article-title: Shark variable new antigen receptor (VNAR) single domain antibody fragments: stability and diagnostic applications
  publication-title: Antibodies
  doi: 10.3390/antib2010066
– volume: 9
  issue: 8
  year: 2011
  ident: 10.1016/j.virusres.2022.199018_bib0067
  article-title: A case of convergence: why did a simple alternative to canonical antibodies arise in sharks and camels?
  publication-title: PLoS Biol.
  doi: 10.1371/journal.pbio.1001120
– volume: 108
  start-page: 9190
  issue: 22
  year: 2011
  ident: 10.1016/j.virusres.2022.199018_bib0201
  article-title: Immune surveillance by mast cells during dengue infection promotes natural killer (NK) and NKT-cell recruitment and viral clearance
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.1105079108
– volume: 60
  start-page: 130
  year: 2014
  ident: 10.1016/j.virusres.2022.199018_bib0219
  article-title: Orientation of llama antibodies strongly increases sensitivity of biosensors
  publication-title: Biosens. Bioelectron.
  doi: 10.1016/j.bios.2014.04.017
– volume: 147
  start-page: 235
  issue: 2
  year: 2008
  ident: 10.1016/j.virusres.2022.199018_bib0029
  article-title: Selection of phage-displayed human antibody fragments on Dengue virus particles captured by a monoclonal antibody: application to the four serotypes
  publication-title: J. Virol. Methods
  doi: 10.1016/j.jviromet.2007.09.001
– volume: 73
  start-page: 4738
  issue: 6
  year: 1999
  ident: 10.1016/j.virusres.2022.199018_bib250
  article-title: Dengue virus structural differences that correlate with pathogenesis
  publication-title: J. Virol
  doi: 10.1128/JVI.73.6.4738-4747.1999
– volume: 31
  start-page: e2161
  issue: 2
  year: 2021
  ident: 10.1016/j.virusres.2022.199018_bib0087
  article-title: Covid-19 and dengue: double punches for dengue-endemic countries in Asia
  publication-title: Rev. Med. Virol.
  doi: 10.1002/rmv.2161
– ident: 10.1016/j.virusres.2022.199018_bib0082
  doi: 10.1016/B978-0-12-625380-1.50010-2
– volume: 100
  start-page: 226
  issue: 1
  year: 2013
  ident: 10.1016/j.virusres.2022.199018_bib0245
  article-title: Human monoclonal ScFv specific to NS1 protein inhibits replication of influenza viruses across types and subtypes
  publication-title: Antiviral Res.
  doi: 10.1016/j.antiviral.2013.07.019
– volume: 17
  start-page: 615
  issue: 6
  year: 2017
  ident: 10.1016/j.virusres.2022.199018_bib0180
  article-title: Safety and immunogenicity of one versus two doses of Takeda's tetravalent dengue vaccine in children in Asia and Latin America: interim results from a phase 2, randomised, placebo-controlled study
  publication-title: Lancet Infect. Dis.
  doi: 10.1016/S1473-3099(17)30166-4
– volume: 40
  start-page: 1840
  issue: 5
  year: 2002
  ident: 10.1016/j.virusres.2022.199018_bib0196
  article-title: Potential application of nonstructural protein NS1 serotype-specific immunoglobulin G enzyme-linked immunosorbent assay in the seroepidemiologic study of dengue virus infection: correlation of results with those of the plaque reduction neutralization test
  publication-title: J. Clin. Microbiol.
  doi: 10.1128/JCM.40.5.1840-1844.2002
– volume: 8
  year: 2017
  ident: 10.1016/j.virusres.2022.199018_bib0088
  article-title: A human antibody against Zika virus crosslinks the E protein to prevent infection
  publication-title: Nat. Commun.
  doi: 10.1038/ncomms14722
– volume: 195
  start-page: 1808
  issue: 12
  year: 2007
  ident: 10.1016/j.virusres.2022.199018_bib0113
  article-title: Dengue virus infects macrophages and dendritic cells in a mouse model of infection
  publication-title: J. Infect. Dis.
  doi: 10.1086/518007
– volume: 181
  start-page: 2
  issue: 1
  year: 2000
  ident: 10.1016/j.virusres.2022.199018_bib254
  article-title: Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity
  publication-title: J. Infect. Dis.
  doi: 10.1086/315215
– volume: 444
  start-page: 405
  issue: 3
  year: 2012
  ident: 10.1016/j.virusres.2022.199018_bib0130
  article-title: The disordered N-terminal region of dengue virus capsid protein contains a lipid-droplet-binding motif
  publication-title: Biochem. J.
  doi: 10.1042/BJ20112219
– volume: 22
  start-page: 564
  issue: 4
  year: 2009
  ident: 10.1016/j.virusres.2022.199018_bib0129
  article-title: Dengue virus pathogenesis: an integrated view
  publication-title: Clin. Microbiol. Rev.
  doi: 10.1128/CMR.00035-09
– volume: 33
  start-page: 7100
  issue: 50
  year: 2015
  ident: 10.1016/j.virusres.2022.199018_bib0075
  article-title: Development of the Sanofi Pasteur tetravalent dengue vaccine: one more step forward
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2015.09.108
– volume: 8
  issue: 10
  year: 2012
  ident: 10.1016/j.virusres.2022.199018_bib0002
  article-title: DENV inhibits type I IFN production in infected cells by cleaving human STING
  publication-title: PLoS Pathog.
  doi: 10.1371/journal.ppat.1002934
– volume: 319
  start-page: 1830
  issue: 5871
  year: 2008
  ident: 10.1016/j.virusres.2022.199018_bib0118
  article-title: The flavivirus precursor membrane-envelope protein complex: structure and maturation
  publication-title: Science
  doi: 10.1126/science.1153263
– volume: 117
  start-page: 17992
  year: 2020
  ident: 10.1016/j.virusres.2022.199018_bib0239
  article-title: A cocrystal structure of dengue capsid protein in complex of inhibitor
  publication-title: Proc. Natl Acad. Sci.
  doi: 10.1073/pnas.2003056117
– volume: 166
  start-page: 1499
  issue: 3
  year: 2001
  ident: 10.1016/j.virusres.2022.199018_bib0094
  article-title: Infection of human dendritic cells by dengue virus causes cell maturation and cytokine production
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.166.3.1499
– volume: 5
  start-page: 318
  issue: 4
  year: 2009
  ident: 10.1016/j.virusres.2022.199018_bib0064
  article-title: Pathogenesis of flavivirus infections: using and abusing the host cell
  publication-title: Cell Host Microbe
  doi: 10.1016/j.chom.2009.04.001
– volume: 44
  start-page: 1775
  issue: 7
  year: 2007
  ident: 10.1016/j.virusres.2022.199018_bib0123
  article-title: Selection of cholera toxin specific IgNAR single-domain antibodies from a naïve shark library
  publication-title: Mol. Immunol.
  doi: 10.1016/j.molimm.2006.07.299
– volume: 5
  issue: 10
  year: 2009
  ident: 10.1016/j.virusres.2022.199018_bib0181
  article-title: Dengue virus capsid protein usurps lipid droplets for viral particle formation
  publication-title: PLoS Pathog.
  doi: 10.1371/journal.ppat.1000632
– volume: 22
  start-page: 5
  issue: 1
  year: 2004
  ident: 10.1016/j.virusres.2022.199018_bib0037
  article-title: Dengue haemorrhagic fever: a global challenge
  publication-title: Indian J. Med. Microbiol.
  doi: 10.1016/S0255-0857(21)02943-1
– volume: 9
  start-page: 1354
  issue: 1
  year: 2020
  ident: 10.1016/j.virusres.2022.199018_bib0170
  article-title: Nurse infected with Covid-19 from a provisional dengue patient
  publication-title: Emerg. Microbes Infect.
  doi: 10.1080/22221751.2020.1775131
– volume: 100
  start-page: 6986
  issue: 12
  year: 2003
  ident: 10.1016/j.virusres.2022.199018_bib251
  article-title: A ligand-binding pocket in the dengue virus envelope glycoprotein
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.0832193100
– volume: 10
  start-page: 1009
  issue: 10
  year: 2010
  ident: 10.1016/j.virusres.2022.199018_bib0168
  article-title: Evaluation of nonstructural 1 antigen assays for the diagnosis and surveillance of dengue in Singapore
  publication-title: Vector Borne Zoonotic Dis.
  doi: 10.1089/vbz.2008.0176
– volume: 496
  start-page: 504
  issue: 7446
  year: 2013
  ident: 10.1016/j.virusres.2022.199018_bib0022
  article-title: The global distribution and burden of dengue
  publication-title: Nature
  doi: 10.1038/nature12060
– volume: 215
  start-page: S89
  issue: suppl_2
  year: 2017
  ident: 10.1016/j.virusres.2022.199018_bib0140
  article-title: Clinical and laboratory diagnosis of Dengue virus infection
  publication-title: J. Infect. Dis.
  doi: 10.1093/infdis/jiw649
– ident: 10.1016/j.virusres.2022.199018_bib0058
– volume: 6
  start-page: e1636
  issue: 5
  year: 2012
  ident: 10.1016/j.virusres.2022.199018_bib0119
  article-title: Development of a humanized antibody with high therapeutic potential against dengue virus type 2
  publication-title: PLOS Negl. Trop. Dis.
  doi: 10.1371/journal.pntd.0001636
– volume: 19
  start-page: 206
  issue: 2
  year: 2018
  ident: 10.1016/j.virusres.2022.199018_bib0174
  article-title: The bright and the dark side of human antibody responses to flaviviruses: lessons for vaccine design
  publication-title: EMBO Rep.
  doi: 10.15252/embr.201745302
– volume: 9
  issue: 409
  year: 2017
  ident: 10.1016/j.virusres.2022.199018_bib0025
  article-title: Rapid antigen tests for dengue virus serotypes and Zika virus in patient serum
  publication-title: Sci. Transl. Med.
  doi: 10.1126/scitranslmed.aan1589
– volume: 71
  start-page: 67
  issue: 1
  year: 2015
  ident: 10.1016/j.virusres.2022.199018_bib0144
  article-title: Discovery of fifth serotype of dengue virus (DENV-5): a new public health dilemma in dengue control
  publication-title: Med. J. Armed Forces India
  doi: 10.1016/j.mjafi.2014.09.011
– volume: 78
  start-page: 368
  issue: 4
  year: 2014
  ident: 10.1016/j.virusres.2022.199018_bib0183
  article-title: Evaluation of the SD BIOLINE Dengue Duo rapid test in the course of acute and convalescent dengue infections in a Mexican endemic region
  publication-title: Diagn. Microbiol. Infect. Dis.
  doi: 10.1016/j.diagmicrobio.2013.12.019
– volume: 4
  start-page: 15841
  issue: 31
  year: 2014
  ident: 10.1016/j.virusres.2022.199018_bib0185
  article-title: A dendrimer matrix for performance enhancement of evanescent wave absorption-based fiber-optic biosensors
  publication-title: RSC Adv.
  doi: 10.1039/C4RA00198B
– volume: 53
  start-page: 1092
  issue: 4
  year: 2015
  ident: 10.1016/j.virusres.2022.199018_bib0155
  article-title: Multicountry prospective clinical evaluation of two enzyme-linked immunosorbent assays and two rapid diagnostic tests for diagnosing dengue fever
  publication-title: J. Clin. Microbiol.
  doi: 10.1128/JCM.03042-14
– volume: 13
  start-page: 387
  issue: 6
  year: 2003
  ident: 10.1016/j.virusres.2022.199018_bib0207
  article-title: Antibody-dependent enhancement of viral infection: molecular mechanisms and in vivo implications
  publication-title: Rev. Med. Virol.
  doi: 10.1002/rmv.405
– volume: 58
  start-page: 710
  issue: 4
  year: 2013
  ident: 10.1016/j.virusres.2022.199018_bib0042
  article-title: Dengue-4 false negative results by Panbio® Dengue Early ELISA assay in Brazil
  publication-title: J. Clin. Virol.
  doi: 10.1016/j.jcv.2013.10.021
– volume: 586
  start-page: 1032
  issue: 7
  year: 2012
  ident: 10.1016/j.virusres.2022.199018_bib0235
  article-title: The dengue virus M protein localises to the endoplasmic reticulum and forms oligomers
  publication-title: FEBS Lett.
  doi: 10.1016/j.febslet.2012.02.047
– volume: 20
  start-page: 536
  issue: 5
  year: 2020
  ident: 10.1016/j.virusres.2022.199018_bib0243
  article-title: Covert COVID-19 and false-positive dengue serology in Singapore
  publication-title: Lancet Infect. Dis.
  doi: 10.1016/S1473-3099(20)30158-4
– volume: 63
  start-page: 140
  issue: 1
  year: 2020
  ident: 10.1016/j.virusres.2022.199018_bib0055
  article-title: Peptide-β-lactam inhibitors of Dengue and West Nile virus NS2B-NS3 protease display two distinct binding modes
  publication-title: J. Med. Chem.
  doi: 10.1021/acs.jmedchem.9b00759
– volume: 7
  start-page: 6975
  issue: 1
  year: 2017
  ident: 10.1016/j.virusres.2022.199018_bib0114
  article-title: Antibodies against modified NS1 wing domain peptide protect against Dengue virus infection
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-017-07308-3
– volume: 9
  start-page: 921
  issue: 7
  year: 2003
  ident: 10.1016/j.virusres.2022.199018_bib0136
  article-title: Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever
  publication-title: Nat. Med.
  doi: 10.1038/nm887
– volume: 12
  start-page: 1607
  issue: 9
  year: 2004
  ident: 10.1016/j.virusres.2022.199018_bib255
  article-title: Conformational changes of the flavivirus E glycoprotein
  publication-title: Structure
  doi: 10.1016/j.str.2004.06.019
– volume: 299
  start-page: 130
  issue: 2
  year: 2010
  ident: 10.1016/j.virusres.2022.199018_bib0110
  article-title: A bispecific antibody effectively inhibits tumor growth and metastasis by simultaneous blocking vascular endothelial growth factor A and osteopontin
  publication-title: Cancer Lett.
  doi: 10.1016/j.canlet.2010.08.011
– volume: 84
  start-page: 183
  issue: Pt 1
  year: 2003
  ident: 10.1016/j.virusres.2022.199018_bib0060
  article-title: Cleavage of protein prM is necessary for infection of BHK-21 cells by tick-borne encephalitis virus
  publication-title: J. Gen. Virol.
  doi: 10.1099/vir.0.18723-0
– volume: 29
  start-page: 960
  issue: 5
  year: 2011
  ident: 10.1016/j.virusres.2022.199018_bib0019
  article-title: Evaluation of a prototype dengue-1 DNA vaccine in a Phase 1 clinical trial
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2010.11.050
– volume: 479
  year: 2020
  ident: 10.1016/j.virusres.2022.199018_bib0089
  article-title: Normal human lymph node T follicular helper cells and germinal center B cells accessed via fine needle aspirations
  publication-title: J. Immunol. Methods
  doi: 10.1016/j.jim.2020.112746
– volume: 22
  start-page: e00927
  year: 2020
  ident: 10.1016/j.virusres.2022.199018_bib0108
  article-title: Dengue serology in Indonesian COVID-19 patients: coinfection or serological overlap?
  publication-title: IDCases
  doi: 10.1016/j.idcr.2020.e00927
– volume: 385
  start-page: 1414
  issue: 8
  year: 2006
  ident: 10.1016/j.virusres.2022.199018_bib0209
  article-title: A novel enhancement assay for immunochromatographic test strips using gold nanoparticles
  publication-title: Anal. Bioanal. Chem.
  doi: 10.1007/s00216-006-0549-4
– volume: 18
  start-page: 2095
  issue: 12
  year: 2011
  ident: 10.1016/j.virusres.2022.199018_bib0024
  article-title: Evaluation of six commercial point-of-care tests for diagnosis of acute dengue infections: the need for combining NS1 antigen and IgM/IgG antibody detection to achieve acceptable levels of accuracy
  publication-title: Clin. Vaccine Immunol.
  doi: 10.1128/CVI.05285-11
– volume: 16
  start-page: 69
  issue: 1
  year: 2003
  ident: 10.1016/j.virusres.2022.199018_bib0215
  article-title: Antibody-dependent enhancement of virus infection and disease
  publication-title: Viral Immunol.
  doi: 10.1089/088282403763635465
– year: 2020
  ident: 10.1016/j.virusres.2022.199018_bib0079
  article-title: ModiBodies: a computational method for modifying nanobodies in nanobody-antigen complexes to improve binding affinity and specificity
  publication-title: J. Biol. Phys.
  doi: 10.1007/s10867-020-09548-3
– ident: 10.1016/j.virusres.2022.199018_bib0142
  doi: 10.1016/B978-0-12-819400-3.00016-8
– volume: 9
  start-page: 532
  issue: 7
  year: 2011
  ident: 10.1016/j.virusres.2022.199018_bib253
  article-title: Fever from the forest: prospects for the continued emergence of sylvatic dengue virus and its impact on public health
  publication-title: Nat. Rev. Microbiol.
  doi: 10.1038/nrmicro2595
– volume: 146
  start-page: w14296
  year: 2016
  ident: 10.1016/j.virusres.2022.199018_bib0078
  article-title: False positive dengue NS1 antigen test in a traveller with an acute Zika virus infection imported into Switzerland
  publication-title: Swiss Med. Wkly.
– volume: 12
  issue: 7
  year: 2017
  ident: 10.1016/j.virusres.2022.199018_bib0117
  article-title: Isolation of serotype-specific antibodies against dengue virus non-structural protein 1 using phage display and application in a multiplexed serotyping assay
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0180669
– volume: 6
  start-page: e17665
  issue: 4
  year: 2011
  ident: 10.1016/j.virusres.2022.199018_bib0097
  article-title: Llama-derived single domain antibodies to build multivalent, superpotent and broadened neutralizing anti-viral molecules
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0017665
– volume: 15
  start-page: 436
  issue: 3
  year: 2009
  ident: 10.1016/j.virusres.2022.199018_bib0098
  article-title: Evaluation of commercially available anti-dengue virus immunoglobulin M tests
  publication-title: Emerg. Infect. Dis.
  doi: 10.3201/eid1503.080923
– volume: 8
  start-page: S30
  issue: 12 Suppl
  year: 2010
  ident: 10.1016/j.virusres.2022.199018_bib0159
  article-title: Evaluation of diagnostic tests: dengue
  publication-title: Nat. Rev. Microbiol.
  doi: 10.1038/nrmicro2459
– start-page: 1
  year: 2020
  ident: 10.1016/j.virusres.2022.199018_bib0092
  article-title: Coronavirus disease of 2019: a mimicker of Dengue infection?
  publication-title: SN Compr. Clin. Med.
– volume: 9
  start-page: 5242
  year: 2018
  ident: 10.1016/j.virusres.2022.199018_bib0101
  article-title: Role of NS1 antibodies in the pathogenesis of acute secondary dengue infection
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-018-07667-z
– volume: 24
  start-page: 203
  issue: 3
  year: 2002
  ident: 10.1016/j.virusres.2022.199018_bib0242
  article-title: Virus isolation as one of the diagnostic methods for dengue virus infection
  publication-title: J. Clin. Virol.
  doi: 10.1016/S1386-6532(01)00250-5
– volume: 79
  start-page: 8004
  issue: 13
  year: 2005
  ident: 10.1016/j.virusres.2022.199018_bib0141
  article-title: Inhibition of alpha/beta interferon signaling by the NS4B protein of flaviviruses
  publication-title: J. Virol.
  doi: 10.1128/JVI.79.13.8004-8013.2005
– volume: 286
  start-page: 8961
  issue: 11
  year: 2011
  ident: 10.1016/j.virusres.2022.199018_bib0099
  article-title: Neutralization of Clostridium difficile toxin a with single-domain antibodies targeting the cell receptor binding domain
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M110.198754
– volume: 40
  start-page: 376
  issue: 2
  year: 2002
  ident: 10.1016/j.virusres.2022.199018_bib0005
  article-title: Enzyme-linked immunosorbent assay specific to Dengue virus type 1 nonstructural protein NS1 reveals circulation of the antigen in the blood during the acute phase of disease in patients experiencing primary or secondary infections
  publication-title: J. Clin. Microbiol.
  doi: 10.1128/JCM.40.02.376-381.2002
– volume: 6
  start-page: e16059
  issue: 1
  year: 2011
  ident: 10.1016/j.virusres.2022.199018_bib0050
  article-title: A broadly flavivirus cross-neutralizing monoclonal antibody that recognizes a novel epitope within the fusion loop of E protein
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0016059
– volume: 84
  start-page: 2771
  issue: Pt 10
  year: 2003
  ident: 10.1016/j.virusres.2022.199018_bib0237
  article-title: Identification of a dengue virus type 2 (DEN-2) serotype-specific B-cell epitope and detection of DEN-2-immunized animal serum samples using an epitope-based peptide antigen
  publication-title: J. Gen. Virol.
  doi: 10.1099/vir.0.19228-0
– volume: 11
  start-page: 479
  year: 2020
  ident: 10.1016/j.virusres.2022.199018_bib0072
  article-title: Rapid induction and maintenance of virus-specific CD8+ TEMRA and CD4+ TEM cells following protective vaccination against Dengue virus challenge in humans
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2020.00479
– volume: 6
  issue: 4
  year: 2010
  ident: 10.1016/j.virusres.2022.199018_bib0194
  article-title: The development of therapeutic antibodies that neutralize homologous and heterologous genotypes of dengue virus type 1
  publication-title: PLoS Pathog.
  doi: 10.1371/journal.ppat.1000823
– volume: 104
  start-page: 293
  issue: 1
  year: 2004
  ident: 10.1016/j.virusres.2022.199018_bib0048
  article-title: Gold nanoparticles: assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnology
  publication-title: Chem. Rev.
  doi: 10.1021/cr030698+
– volume: 79
  start-page: 1223
  issue: 2
  year: 2005
  ident: 10.1016/j.virusres.2022.199018_bib0134
  article-title: Variable surface epitopes in the crystal structure of dengue virus type 3 envelope glycoprotein
  publication-title: J. Virol.
  doi: 10.1128/JVI.79.2.1223-1231.2005
– volume: 22
  start-page: 55
  issue: 1
  year: 2015
  ident: 10.1016/j.virusres.2022.199018_bib0222
  article-title: The performance of the SD BIOLINE Dengue DUO® rapid immunochromatographic test kit for the detection of NS1 antigen, IgM and IgG antibodies during a dengue type 1 epidemic in Jamaica
  publication-title: J. Biomed. Sci.
  doi: 10.1186/s12929-015-0164-9
– year: 2020
  ident: 10.1016/j.virusres.2022.199018_bib0006
  article-title: Genomic epidemiology of SARS-CoV-2 reveals multiple lineages and early spread of SARS-CoV-2 infections in Lombardy, Italy
  publication-title: medRxiv
– ident: 10.1016/j.virusres.2022.199018_bib0232
– ident: 10.1016/j.virusres.2022.199018_bib0001
– volume: 87
  start-page: 8870
  issue: 16
  year: 2013
  ident: 10.1016/j.virusres.2022.199018_bib0103
  article-title: Role of RNA interference (RNAi) in dengue virus replication and identification of NS4B as an RNAi suppressor
  publication-title: J. Virol.
  doi: 10.1128/JVI.02774-12
– volume: 7
  issue: 4
  year: 2019
  ident: 10.1016/j.virusres.2022.199018_bib0216
  article-title: The interplay between Dengue virus and the human innate immune system: a game of hide and seek
  publication-title: Vaccines
  doi: 10.3390/vaccines7040145
– volume: 385
  start-page: 453
  issue: 9966
  year: 2015
  ident: 10.1016/j.virusres.2022.199018_bib0076
  article-title: Dengue
  publication-title: Lancet
  doi: 10.1016/S0140-6736(14)60572-9
– volume: 22
  start-page: 1399
  issue: 11
  year: 2004
  ident: 10.1016/j.virusres.2022.199018_bib0018
  article-title: Recombinant protein folding and misfolding in Escherichia coli
  publication-title: Nat. Biotechnol.
  doi: 10.1038/nbt1029
– volume: 16
  start-page: 170
  issue: 2
  year: 2015
  ident: 10.1016/j.virusres.2022.199018_bib0049
  article-title: A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus
  publication-title: Nat. Immunol.
  doi: 10.1038/ni.3058
– volume: 18
  start-page: E8
  issue: 1
  year: 2012
  ident: 10.1016/j.virusres.2022.199018_bib0071
  article-title: Evaluation and use of NS1 IgM antibody detection for acute dengue virus diagnosis: report from an outbreak investigation
  publication-title: Clin. Microbiol. Infect.
  doi: 10.1111/j.1469-0691.2011.03694.x
– volume: 4
  start-page: e08347
  year: 2015
  ident: 10.1016/j.virusres.2022.199018_bib0111
  article-title: The global distribution of the arbovirus vectors Aedes aegypti and Ae. albopictus
  publication-title: Elife
  doi: 10.7554/eLife.08347
– volume: 83
  start-page: 690
  issue: 3
  year: 2010
  ident: 10.1016/j.virusres.2022.199018_bib0226
  article-title: Early diagnosis of Dengue infection using a commercial Dengue Duo rapid test kit for the detection of NS1, IgM, and IgG
  publication-title: Am. J. Trop. Med. Hyg.
  doi: 10.4269/ajtmh.2010.10-0117
– volume: 456-457
  start-page: 96
  year: 2014
  ident: 10.1016/j.virusres.2022.199018_bib0139
  article-title: Abrogation of TLR3 inhibition by discrete amino acid changes in the C-terminal half of the West Nile virus NS1 protein
  publication-title: Virology
  doi: 10.1016/j.virol.2014.03.017
– volume: 7
  start-page: 361
  year: 2010
  ident: 10.1016/j.virusres.2022.199018_bib0153
  article-title: Comparison of the diagnostic accuracy of commercial NS1-based diagnostic tests for early dengue infection
  publication-title: Virol. J.
  doi: 10.1186/1743-422X-7-361
– volume: 6
  start-page: e20528
  issue: 7
  year: 2011
  ident: 10.1016/j.virusres.2022.199018_bib0016
  article-title: DNA vaccines against dengue virus type 2 based on truncate envelope protein or its domain III
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0020528
– volume: 108
  start-page: 12479
  issue: 30
  year: 2011
  ident: 10.1016/j.virusres.2022.199018_bib0034
  article-title: Ligation of Fc gamma receptor IIB inhibits antibody-dependent enhancement of dengue virus infection
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.1106568108
– volume: 69
  start-page: 82
  issue: 1
  year: 2003
  ident: 10.1016/j.virusres.2022.199018_bib0121
  article-title: Antibodies from dengue patient sera cross-react with endothelial cells and induce damage
  publication-title: J. Med. Virol.
  doi: 10.1002/jmv.10261
– volume: 15
  start-page: 312
  issue: 3
  year: 2008
  ident: 10.1016/j.virusres.2022.199018_bib0125
  article-title: Binding of a neutralizing antibody to dengue virus alters the arrangement of surface glycoproteins
  publication-title: Nat. Struct. Mol. Biol.
  doi: 10.1038/nsmb.1382
– volume: 14
  start-page: 1342
  issue: 13
  year: 2017
  ident: 10.1016/j.virusres.2022.199018_bib0039
  article-title: Peptides as therapeutic agents for Dengue virus
  publication-title: Int. J. Med. Sci.
  doi: 10.7150/ijms.21875
– volume: 9
  start-page: e92495
  issue: 3
  year: 2014
  ident: 10.1016/j.virusres.2022.199018_bib0224
  article-title: Protection against dengue virus infection in mice by administration of antibodies against modified nonstructural protein 1
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0092495
– volume: 8
  start-page: 428
  issue: 11
  year: 1998
  ident: 10.1016/j.virusres.2022.199018_bib0059
  article-title: C1q—How many functions? How many receptors?
  publication-title: Trends Cell Biol.
  doi: 10.1016/S0962-8924(98)01373-7
– volume: 142
  year: 2021
  ident: 10.1016/j.virusres.2022.199018_bib0095
  article-title: Review of antiviral peptides for use against zoonotic and selected non-zoonotic viruses
  publication-title: Peptides
  doi: 10.1016/j.peptides.2021.170570
– volume: 449
  start-page: 419
  issue: 7161
  year: 2007
  ident: 10.1016/j.virusres.2022.199018_bib0203
  article-title: Taking dendritic cells into medicine
  publication-title: Nature
  doi: 10.1038/nature06175
– volume: 6
  start-page: 6341
  year: 2015
  ident: 10.1016/j.virusres.2022.199018_bib0066
  article-title: A highly potent human antibody neutralizes dengue virus serotype 3 by binding across three surface proteins
  publication-title: Nat. Commun.
  doi: 10.1038/ncomms7341
– volume: 17
  start-page: 560
  issue: 11
  year: 2013
  ident: 10.1016/j.virusres.2022.199018_bib0179
  article-title: Antiviral cationic peptides as a strategy for innovation in global health therapeutics for dengue virus: high yield production of the biologically active recombinant plectasin peptide
  publication-title: OMICS
  doi: 10.1089/omi.2013.0056
– volume: 98
  start-page: 1684
  issue: 7
  year: 1996
  ident: 10.1016/j.virusres.2022.199018_bib0132
  article-title: Dominant recognition by human CD8+ cytotoxic T lymphocytes of dengue virus nonstructural proteins NS3 and NS1.2a
  publication-title: J. Clin. Invest.
  doi: 10.1172/JCI118964
– volume: 9
  start-page: e95263
  issue: 4
  year: 2014
  ident: 10.1016/j.virusres.2022.199018_bib0061
  article-title: Development of VHH antibodies against dengue virus type 2 NS1 and comparison with monoclonal antibodies for use in immunological diagnosis
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0095263
– volume: 174
  start-page: 8163
  issue: 12
  year: 2005
  ident: 10.1016/j.virusres.2022.199018_bib0093
  article-title: Dengue virus type 2 antagonizes IFN-alpha but not IFN-gamma antiviral effect via down-regulating Tyk2-STAT signaling in the human dendritic cell
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.174.12.8163
– volume: 59
  start-page: 141
  year: 2003
  ident: 10.1016/j.virusres.2022.199018_bib0177
  article-title: Antigenic structure of flavivirus proteins
  publication-title: Adv. Virus Res.
  doi: 10.1016/S0065-3527(03)59005-4
– volume: 102
  start-page: 152
  year: 2021
  ident: 10.1016/j.virusres.2022.199018_bib0131
  article-title: Serological cross-reaction and coinfection of dengue and COVID-19 in Asia: experience from Indonesia
  publication-title: Int. J. Infect. Dis.
  doi: 10.1016/j.ijid.2020.10.043
– volume: 16
  start-page: 88
  issue: 1
  year: 2009
  ident: 10.1016/j.virusres.2022.199018_bib0171
  article-title: Development of an antigen capture immunoassay based on monoclonal antibodies specific for dengue virus serotype 2 nonstructural protein 1 for early and rapid identification of dengue virus serotype 2 infections
  publication-title: Clin. Vaccine Immunol.
  doi: 10.1128/CVI.00212-08
– volume: 260
  start-page: 109
  year: 2001
  ident: 10.1016/j.virusres.2022.199018_bib0026
  article-title: A model for neutralization of viruses based on antibody coating of the virion surface
  publication-title: Curr. Top. Microbiol. Immunol.
– volume: 10
  year: 2020
  ident: 10.1016/j.virusres.2022.199018_bib0147
  article-title: Intrinsic ADE: the dark side of antibody dependent enhancement during Dengue infection
  publication-title: Front. Cell Infect. Microbiol.
  doi: 10.3389/fcimb.2020.580096
– volume: 33
  start-page: 3746
  issue: 31
  year: 2015
  ident: 10.1016/j.virusres.2022.199018_bib0053
  article-title: Modelling the immunological response to a tetravalent dengue vaccine from multiple phase-2 trials in Latin America and South East Asia
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2015.05.059
– volume: 19
  start-page: 1972
  issue: 12
  year: 2012
  ident: 10.1016/j.virusres.2022.199018_bib0062
  article-title: Low sensitivity of NS1 protein tests evidenced during a dengue type 2 virus outbreak in Santos, Brazil, in 2010
  publication-title: Clin. Vaccine Immunol.
  doi: 10.1128/CVI.00535-12
– volume: 7
  year: 2016
  ident: 10.1016/j.virusres.2022.199018_bib0248
  article-title: Neutralization mechanism of a highly potent antibody against Zika virus
  publication-title: Nat. Commun.
  doi: 10.1038/ncomms13679
– volume: 5
  year: 2015
  ident: 10.1016/j.virusres.2022.199018_bib0010
  article-title: Quantification of NS1 dengue biomarker in serum via optomagnetic nanocluster detection
  publication-title: Sci. Rep.
  doi: 10.1038/srep16145
– volume: 352
  start-page: 467
  issue: 6284
  year: 2016
  ident: 10.1016/j.virusres.2022.199018_bib0199
  article-title: The 3.8 Å resolution cryo-EM structure of Zika virus
  publication-title: Science
  doi: 10.1126/science.aaf5316
– volume: 23
  start-page: 1396
  issue: 6
  year: 2009
  ident: 10.1016/j.virusres.2022.199018_bib252
  article-title: Changing drivers of deforestation and new opportunities for conservation
  publication-title: Conserv. Biol.
  doi: 10.1111/j.1523-1739.2009.01332.x
– volume: 8
  start-page: e64056
  issue: 5
  year: 2013
  ident: 10.1016/j.virusres.2022.199018_bib0189
  article-title: Underreporting of Dengue-4 in Brazil due to low sensitivity of the NS1 Ag test in routine control programs
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0064056
– volume: 423
  start-page: 867
  issue: 4
  year: 2012
  ident: 10.1016/j.virusres.2022.199018_bib0190
  article-title: Human monoclonal antibodies to neutralize all dengue virus serotypes using lymphocytes from patients at acute phase of the secondary infection
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1016/j.bbrc.2012.06.057
– volume: 2
  start-page: 49
  year: 2005
  ident: 10.1016/j.virusres.2022.199018_bib0096
  article-title: Peptide inhibitors of dengue virus and West Nile virus infectivity
  publication-title: Virol. J.
  doi: 10.1186/1743-422X-2-49
– volume: 171
  start-page: 229
  issue: 1
  year: 2017
  ident: 10.1016/j.virusres.2022.199018_bib0225
  article-title: A human bi-specific antibody against Zika virus with high therapeutic potential
  publication-title: Cell
  doi: 10.1016/j.cell.2017.09.002
– volume: 6
  start-page: e1993
  issue: 12
  year: 2012
  ident: 10.1016/j.virusres.2022.199018_bib0009
  article-title: Field evaluation and impact on clinical management of a rapid diagnostic kit that detects dengue NS1, IgM and IgG
  publication-title: PLOS Negl. Trop. Dis.
  doi: 10.1371/journal.pntd.0001993
– volume: 64
  start-page: 153
  issue: 2
  year: 2020
  ident: 10.1016/j.virusres.2022.199018_bib0074
  article-title: A synthetic peptide analog of in silico-predicted immunogenic epitope unique to dengue virus serotype 2 NS1 antigen specifically binds immunoglobulin G antibodies raised in rabbits
  publication-title: Microbiol. Immunol.
  doi: 10.1111/1348-0421.12757
– volume: 342
  start-page: 415
  issue: 6157
  year: 2013
  ident: 10.1016/j.virusres.2022.199018_bib0150
  article-title: Tropical medicine. Surprising new dengue virus throws a spanner in disease control efforts
  publication-title: Science
  doi: 10.1126/science.342.6157.415
– volume: 14
  start-page: 140
  year: 2014
  ident: 10.1016/j.virusres.2022.199018_bib0178
  article-title: Identification of natural antimicrobial agents to treat dengue infection: in vitro analysis of latarcin peptide activity against dengue virus
  publication-title: BMC Microbiol.
  doi: 10.1186/1471-2180-14-140
– volume: 86
  start-page: 13486
  issue: 24
  year: 2012
  ident: 10.1016/j.virusres.2022.199018_bib0188
  article-title: Noncoding flavivirus RNA displays RNA interference suppressor activity in insect and Mammalian cells
  publication-title: J. Virol.
  doi: 10.1128/JVI.01104-12
– volume: 8
  start-page: 574
  issue: 3
  year: 2016
  ident: 10.1016/j.virusres.2022.199018_bib0193
  article-title: A bispecific antibody effectively neutralizes all four serotypes of dengue virus by simultaneous blocking virus attachment and fusion
  publication-title: MAbs
  doi: 10.1080/19420862.2016.1148850
– volume: 8
  start-page: 1
  issue: 1802
  year: 2017
  ident: 10.1016/j.virusres.2022.199018_bib0238
  article-title: Single-domain antibodies as therapeutics against human viral diseases
  publication-title: Front. Immunol.
– volume: 67
  start-page: 2773
  issue: 16
  year: 2010
  ident: 10.1016/j.virusres.2022.199018_bib0176
  article-title: Dengue virus life cycle: viral and host factors modulating infectivity
  publication-title: Cell. Mol. Life Sci.
  doi: 10.1007/s00018-010-0357-z
– ident: 10.1016/j.virusres.2022.199018_bib0156
  doi: 10.1089/apc.1997.11.429
– volume: 201
  start-page: 923
  issue: 6
  year: 2010
  ident: 10.1016/j.virusres.2022.199018_bib0221
  article-title: Mechanisms of immune evasion induced by a complex of dengue virus and preexisting enhancing antibodies
  publication-title: J. Infect. Dis.
  doi: 10.1086/651018
– volume: 19
  start-page: 218
  issue: 4
  year: 2019
  ident: 10.1016/j.virusres.2022.199018_bib0202
  article-title: Adaptive immune responses to primary and secondary dengue virus infections
  publication-title: Nat. Rev. Immunol.
  doi: 10.1038/s41577-019-0123-x
– volume: 598
  start-page: 504
  issue: 7881
  year: 2021
  ident: 10.1016/j.virusres.2022.199018_bib0106
  article-title: A pan-serotype dengue virus inhibitor targeting the NS3-NS4B interaction
  publication-title: Nature
  doi: 10.1038/s41586-021-03990-6
– volume: 75
  start-page: 3501
  issue: 8
  year: 2001
  ident: 10.1016/j.virusres.2022.199018_bib0120
  article-title: Human dendritic cells are activated by dengue virus infection: enhancement by gamma interferon and implications for disease pathogenesis
  publication-title: J. Virol.
  doi: 10.1128/JVI.75.8.3501-3508.2001
– volume: 27
  start-page: 3586
  issue: 15
  year: 2017
  ident: 10.1016/j.virusres.2022.199018_bib0208
  article-title: Discovery of novel cyclic peptide inhibitors of dengue virus NS2B-NS3 protease with antiviral activity
  publication-title: Bioorg. Med. Chem. Lett.
  doi: 10.1016/j.bmcl.2017.05.027
– volume: 343
  start-page: 881
  issue: 6173
  year: 2014
  ident: 10.1016/j.virusres.2022.199018_bib0004
  article-title: Flavivirus NS1 structures reveal surfaces for associations with membranes and the immune system
  publication-title: Science
  doi: 10.1126/science.1247749
– volume: 187
  start-page: 424
  issue: 1
  year: 2011
  ident: 10.1016/j.virusres.2022.199018_bib0013
  article-title: Binding of flavivirus nonstructural protein NS1 to C4b binding protein modulates complement activation
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.1100750
– volume: 33
  start-page: 7126
  issue: 50
  year: 2015
  ident: 10.1016/j.virusres.2022.199018_bib0127
  article-title: Preclinical and clinical development of a dengue recombinant subunit vaccine
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2015.09.101
– volume: 12
  start-page: 136
  issue: 2
  year: 2012
  ident: 10.1016/j.virusres.2022.199018_bib0204
  article-title: Expanding roles for CD4⁺ T cells in immunity to viruses
  publication-title: Nat. Rev. Immunol.
  doi: 10.1038/nri3152
– volume: 101
  start-page: 925
  issue: 8
  year: 2006
  ident: 10.1016/j.virusres.2022.199018_bib0011
  article-title: Concurrent infection with dengue virus type-2 and DENV-3 in a patient from Ceará, Brazil
  publication-title: Mem. Inst. Oswaldo Cruz.
  doi: 10.1590/S0074-02762006000800017
– volume: 10
  start-page: 317
  issue: 2
  year: 2003
  ident: 10.1016/j.virusres.2022.199018_bib0017
  article-title: Diagnosis of dengue virus infection by detection of specific immunoglobulin M (IgM) and IgA antibodies in serum and saliva
  publication-title: Clin. Diagn. Lab. Immunol.
– volume: 39
  start-page: 155
  issue: 2
  year: 2015
  ident: 10.1016/j.virusres.2022.199018_bib0046
  article-title: Receptors and routes of dengue virus entry into the host cells
  publication-title: FEMS Microbiol. Rev.
  doi: 10.1093/femsre/fuu004
– volume: 8
  issue: 5
  year: 2016
  ident: 10.1016/j.virusres.2022.199018_bib0107
  article-title: Dengue virus reporter replicon is a valuable tool for antiviral drug discovery and analysis of virus replication mechanisms
  publication-title: Viruses
  doi: 10.3390/v8050122
– volume: 10
  start-page: 142
  year: 2010
  ident: 10.1016/j.virusres.2022.199018_bib0217
  article-title: Comparison of two dengue NS1 rapid tests for sensitivity, specificity and relationship to viraemia and antibody responses
  publication-title: BMC Infect. Dis.
  doi: 10.1186/1471-2334-10-142
– volume: 98
  start-page: 423
  issue: 3
  year: 2013
  ident: 10.1016/j.virusres.2022.199018_bib0184
  article-title: Dengue virus neutralization and antibody-dependent enhancement activities of human monoclonal antibodies derived from dengue patients at acute phase of secondary infection
  publication-title: Antiviral Res.
  doi: 10.1016/j.antiviral.2013.03.018
– volume: 39
  start-page: 977
  issue: 3
  year: 2001
  ident: 10.1016/j.virusres.2022.199018_bib0236
  article-title: Identification of B-cell epitope of dengue virus type 1 and its application in diagnosis of patients
  publication-title: J. Clin. Microbiol.
  doi: 10.1128/JCM.39.3.977-982.2001
– volume: 86
  start-page: 7360
  issue: 13
  year: 2012
  ident: 10.1016/j.virusres.2022.199018_bib0246
  article-title: Evidence for a genetic and physical interaction between nonstructural proteins NS1 and NS4B that modulates replication of West Nile virus
  publication-title: J. Virol.
  doi: 10.1128/JVI.00157-12
– volume: 52
  start-page: 855
  issue: 10
  year: 2013
  ident: 10.1016/j.virusres.2022.199018_bib0051
  article-title: Pharmacokinetics and pharmacokinetic-pharmacodynamic correlations of therapeutic peptides
  publication-title: Clin. Pharmacokinet.
  doi: 10.1007/s40262-013-0079-0
– volume: 2
  issue: 9
  year: 2002
  ident: 10.1016/j.virusres.2022.199018_bib0031
  article-title: Antibodies against prM protein distinguish between previous infection with dengue and Japanese encephalitis viruses
  publication-title: BMC Microbiol.
– volume: 11
  start-page: 42
  issue: 1
  year: 1999
  ident: 10.1016/j.virusres.2022.199018_bib0149
  article-title: C1q-binding proteins and C1q receptors
  publication-title: Curr. Opin. Immunol.
  doi: 10.1016/S0952-7915(99)80008-9
– volume: 3
  start-page: 767
  issue: 10
  year: 2017
  ident: 10.1016/j.virusres.2022.199018_bib0182
  article-title: Surface-enhanced Raman spectroscopy-based sandwich immunoassays for multiplexed detection of Zika and Dengue viral biomarkers
  publication-title: ACS Infect. Dis.
  doi: 10.1021/acsinfecdis.7b00110
– volume: 45
  start-page: 11
  issue: 1
  year: 2003
  ident: 10.1016/j.virusres.2022.199018_bib0054
  article-title: Molecular characterization of dengue viruses type 1 and 2 isolated from a concurrent human infection
  publication-title: Rev. Inst. Med. Trop. Sao Paulo
  doi: 10.1590/S0036-46652003000100003
– volume: 42
  start-page: 465
  year: 1964
  ident: 10.1016/j.virusres.2022.199018_bib0090
  article-title: Enhancement of the infectivity of arboviruses by specific antisera produced in domestic fowls
  publication-title: Aust. J. Exp. Biol. Med. Sci.
  doi: 10.1038/icb.1964.44
– volume: 1
  start-page: 101
  year: 2016
  ident: 10.1016/j.virusres.2022.199018_bib0210
  article-title: A putative fifth serotype of Dengue - potential implications for diagnosis, therapy and vaccine design
  publication-title: Int. J. Clin. Med. Microbiol.
  doi: 10.15344/2456-4028/2016/101
– volume: 60
  start-page: 387
  issue: 4
  year: 2008
  ident: 10.1016/j.virusres.2022.199018_bib0116
  article-title: Evaluation of an NS1 antigen detection for diagnosis of acute dengue infection in patients with acute febrile illness
  publication-title: Diagn. Microbiol. Infect. Dis.
  doi: 10.1016/j.diagmicrobio.2007.11.010
– volume: 14
  start-page: 299
  issue: 7
  year: 2021
  ident: 10.1016/j.virusres.2022.199018_bib0021
  article-title: Plasmid DNA encoding neutralizing human monoclonal antibody without enhancing activity protects against dengue virus infection in mice
  publication-title: Asian Pac. J. Trop. Med.
  doi: 10.4103/1995-7645.320520
– volume: 15
  start-page: 2295
  issue: 10
  year: 2019
  ident: 10.1016/j.virusres.2022.199018_bib0214
  article-title: A review of Dengvaxia®: development to deployment
  publication-title: Hum. Vaccin. Immunother.
  doi: 10.1080/21645515.2019.1658503
– volume: 36
  start-page: 89
  issue: 2
  year: 2003
  ident: 10.1016/j.virusres.2022.199018_bib0227
  article-title: Concurrent infections by two dengue virus serotypes among dengue patients in Taiwan
  publication-title: J. Microbiol. Immunol. Infect.
– volume: 41
  start-page: 4154
  issue: 9
  year: 2003
  ident: 10.1016/j.virusres.2022.199018_bib0109
  article-title: Detection of immune-complex-dissociated nonstructural-1 antigen in patients with acute dengue virus infections
  publication-title: J. Clin. Microbiol.
  doi: 10.1128/JCM.41.9.4154-4159.2003
– volume: 80
  start-page: 2170
  issue: 5
  year: 2006
  ident: 10.1016/j.virusres.2022.199018_bib0041
  article-title: RNA secondary structure in the coding region of dengue virus type 2 directs translation start codon selection and is required for viral replication
  publication-title: J. Virol.
  doi: 10.1128/JVI.80.5.2170-2182.2006
– volume: 12
  start-page: e1584
  issue: 1
  year: 2020
  ident: 10.1016/j.virusres.2022.199018_bib0167
  article-title: Single and multiple detections of foodborne pathogens by gold nanoparticle assays
  publication-title: Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol.
  doi: 10.1002/wnan.1584
– volume: 1
  start-page: 49
  issue: 1
  year: 2007
  ident: 10.1016/j.virusres.2022.199018_bib0223
  article-title: NMR assignments of the yellow fever virus envelope protein domain III
  publication-title: Biomol. NMR Assign.
  doi: 10.1007/s12104-007-9000-9
– volume: 14
  start-page: 1452
  issue: 7
  year: 2022
  ident: 10.1016/j.virusres.2022.199018_bib0166
  article-title: Combination of E- and NS1-derived DNA vaccines: the immune response and protection elicited in mice against DENV2
  publication-title: Viruses
  doi: 10.3390/v14071452
– volume: 91
  start-page: 2395
  issue: 7
  year: 1994
  ident: 10.1016/j.virusres.2022.199018_bib0135
  article-title: Dengue: the risk to developed and developing countries
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.91.7.2395
– volume: 10
  start-page: 1522
  year: 2019
  ident: 10.1016/j.virusres.2022.199018_bib0165
  article-title: T cell responses induced by DNA vaccines based on the DENV2 E and NS1 proteins in mice: importance in protection and immunodominant epitope identification
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2019.01522
– volume: 9
  start-page: 13483
  issue: 1
  year: 2019
  ident: 10.1016/j.virusres.2022.199018_bib0146
  article-title: Detection of dengue using PAMAM dendrimer integrated tapered optical fiber sensor
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-019-49891-7
– volume: 6
  start-page: 474
  issue: 2
  year: 2014
  ident: 10.1016/j.virusres.2022.199018_bib0169
  article-title: Generation of human single-chain variable fragment antibodies specific to dengue virus non-structural protein 1 that interfere with the virus infectious cycle
  publication-title: MAbs
  doi: 10.4161/mabs.27874
– volume: 138
  start-page: 1619
  issue: 6
  year: 2013
  ident: 10.1016/j.virusres.2022.199018_bib0218
  article-title: Antibody orientation on biosensor surfaces: a minireview
  publication-title: Analyst
  doi: 10.1039/c2an36787d
– volume: 2019
  year: 2019
  ident: 10.1016/j.virusres.2022.199018_bib0137
  article-title: Cross-reaction, enhancement, and neutralization activity of Dengue virus antibodies against Zika virus: a study in the Mexican population
  publication-title: J. Immunol. Res.
  doi: 10.1155/2019/7239347
– volume: 13
  issue: 3
  year: 2019
  ident: 10.1016/j.virusres.2022.199018_bib0249
  article-title: Virulence difference of five type I dengue viruses and the intrinsic molecular mechanism
  publication-title: PLOS Negl. Trop. Dis.
  doi: 10.1371/journal.pntd.0007202
– volume: 9
  issue: 405
  year: 2017
  ident: 10.1016/j.virusres.2022.199018_bib0198
  article-title: Increased adaptive immune responses and proper feedback regulation protect against clinical dengue
  publication-title: Sci. Transl. Med.
  doi: 10.1126/scitranslmed.aal5088
– volume: 196
  start-page: S347
  issue: Supplement_2
  year: 2007
  ident: 10.1016/j.virusres.2022.199018_bib0205
  article-title: Epitopes required for antibody-dependent enhancement of Ebola virus infection
  publication-title: J. Infect. Dis.
  doi: 10.1086/520581
– volume: 4
  start-page: 229
  issue: 3
  year: 2008
  ident: 10.1016/j.virusres.2022.199018_bib0163
  article-title: Structural insights into the mechanisms of antibody-mediated neutralization of flavivirus infection: implications for vaccine development
  publication-title: Cell Host Microbe
  doi: 10.1016/j.chom.2008.08.004
– volume: 319
  start-page: 1834
  issue: 5871
  year: 2008
  ident: 10.1016/j.virusres.2022.199018_bib0247
  article-title: Structure of the immature dengue virus at low pH primes proteolytic maturation
  publication-title: Science
  doi: 10.1126/science.1153264
– volume: 19
  start-page: 500
  issue: 3
  year: 1994
  ident: 10.1016/j.virusres.2022.199018_bib0138
  article-title: Antibody-dependent enhancement of infection and the pathogenesis of viral disease
  publication-title: Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am.
  doi: 10.1093/clinids/19.3.500
– ident: 10.1016/j.virusres.2022.199018_bib0033
– volume: 18
  start-page: 430
  issue: 3
  year: 2011
  ident: 10.1016/j.virusres.2022.199018_bib0052
  article-title: Full serotype- and group-specific NS1 capture enzyme-linked immunosorbent assay for rapid differential diagnosis of dengue virus infection
  publication-title: Clin. Vaccine Immunol.
  doi: 10.1128/CVI.00462-10
SSID ssj0006376
Score 2.6012664
SecondaryResourceType review_article
Snippet •Reviews on unsolved issues of DENV from different perspectives such as the effect of antibody dependent enhancement, immune escape and limitations of...
The transmission of dengue virus (DENV) from an infected Aedes mosquito to a human, causes illness ranging from mild dengue fever to fatal dengue shock...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 199018
SubjectTerms Animals
Antibodies, Neutralizing
Antibodies, Viral - therapeutic use
Cross reaction
Dengue - diagnosis
Dengue - prevention & control
Dengue Vaccines
Dengue Virus
DENV
Development
Diagnostic
Humans
Therapeutic
Vaccines
Title Dengue virus infection – a review of pathogenesis, vaccines, diagnosis and therapy
URI https://dx.doi.org/10.1016/j.virusres.2022.199018
https://www.ncbi.nlm.nih.gov/pubmed/36493993
https://www.proquest.com/docview/2753299881
Volume 324
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LS8QwEA6iCF7Et-tjieDRut1tkqbHZVVWBS8qeCtJO126SHfZF-xF_A_-Q3-JmaRdFRQP3kpISJhJZ74kM_MRchqEPFSKgwfmzOMxCJUnZZp6Aloi4xIMKLcBsnei-8hunvjTEulUuTAYVlnafmfTrbUuWxqlNBvDPG_cG7CC1eWMg8MiKzaPnLEQd_n5y2eYhwgswRx29rD3lyzh_vksH02NJ8Ky3a0WJu75SP7xs4P6DYBaR3S1QdZLBEnbbpGbZAmKLbLqOCXn2-ThAoreFKidlFaxVgV9f32jirpMFTrIKFIRD3po6fLxGZ2pBF_YzVfqYu_yMVVFSl161nyHPF5dPnS6Xkmd4CUGYU28MBEJFvwUBjsLhem0UmUsYExF3DT4OuDIsZH5EpgPWmuljQxTaGUs9SFpBrtkuRgUsE-oTH0dCoi0n2VMB6lsKs2CEPxI84hDUiO8kleclHXFkd7iOa4CyPpxJecY5Rw7OddIYzFu6Cpr_DkiqtQRf9sjsTH_f449qfQXmx8IX0VUAYOp6WQObMYnS9mskT2n2MV6AsEiRHAH_5j5kKwhRT1e2zT5EVmejKZwbIDMRNftTq2Tlfb1bfeubq8D6va-6QPNUvXA
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NbtQwEB6VIgQXxD_Lr5Hghrv5sZ3kwAFRqi0tvbCVejN2MqlSoWzV3S3aC-IdeBTeiCdhJk4KSKAeUG-RE8fWjD3zWf5mBuB5munMOY0S6cwjFWZO5nlVSYOJqXWOBMo7guyemeyrdwf6YA2-D7EwTKvsbX-w6Z217lvGvTTHx00z_kBghbPLkYPjJCtZ3DMrd3D1mc5t81fbm6TkF0my9Xb6ZiL70gKyJASykFlpSk6IaQhbGsfhprmrVaqUKzQ1RD7VXIOijnJUEXrvnacxKkxqVUVYxin99xJcVmQuuGzCxpdfvBKTdhXteHaSp_dbWPLRxmlzsiTXx3nCk4QjBSOuNvJ3j_gvxNt5vq0bcL2HrOJ1kMpNWMP2FlwJRSxXt2G6ie3hEkU3qBjIXa348fWbcCKExohZLbj28eyQTWszfylOXclX-vRUBbJfMxeurUSIB1vdgf0LEehdWG9nLd4HkVeRzwwWPqpr5dMqj51XaYZR4XWhsRyBHuRlyz6ROdfT-GQHxtqRHeRsWc42yHkE47N-xyGVx7k9ikEd9o9FacnfnNv32aA_SzuWr2Fci7MlfUQnRAIBeR6P4F5Q7Nl8UqMKhowP_mPkp3B1Mn2_a3e393YewjV6w4w5GetHsL44WeJjQlEL_6RbtQI-XvQ2-QkWNy5g
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Dengue+virus+infection+%E2%80%93+a+review+of+pathogenesis%2C+vaccines%2C+diagnosis+and+therapy&rft.jtitle=Virus+research&rft.au=Kok%2C+Boon+Hui&rft.au=Lim%2C+Hui+Ting&rft.au=Lim%2C+Chin+Peng&rft.au=Lai%2C+Ngit+Shin&rft.date=2023-01-15&rft.pub=Elsevier+B.V&rft.issn=0168-1702&rft.eissn=1872-7492&rft.volume=324&rft_id=info:doi/10.1016%2Fj.virusres.2022.199018&rft.externalDocID=S0168170222003471
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0168-1702&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0168-1702&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0168-1702&client=summon